Charles G. Eberhart, MD PhD - Publications

Affiliations: 
Pathology Johns Hopkins University, Baltimore, MD 
Area:
pathology and molecular biology of pediatric brain tumors
Website:
http://pds17.pathology.jhmi.edu/N/n.web?EP=N&URL=/MCGI/SEND^WEBUTLTY(1058)/1543522402

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Gharagozloo M, Smith MD, Jin J, Garton T, Taylor M, Chao A, Meyers K, Kornberg MD, Zack DJ, Ohayon J, Calabresi BA, Reich DS, Eberhart CG, Pardo CA, Kemper C, et al. Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation. Acta Neuropathologica. PMID 34487221 DOI: 10.1007/s00401-021-02366-4  1
2021 Peterson C, Moore R, Hicks JL, Morsberger LA, De Marzo AM, Zou Y, Eberhart CG, Campbell AA. NGS Analysis Confirms Common and Mutations, and Suggests Amplification in Ocular Adnexal Sebaceous Carcinomas. International Journal of Molecular Sciences. 22. PMID 34445161 DOI: 10.3390/ijms22168454  1
2021 Coltin H, Sundaresan L, Smith KS, Skowron P, Massimi L, Eberhart CG, Schreck KC, Gupta N, Weiss WA, Tirapelli D, Carlotti C, Li KKW, Ryzhova M, Golanov A, Zheludkova O, et al. Subgroup and subtype-specific outcomes in adult medulloblastoma. Acta Neuropathologica. PMID 34409497 DOI: 10.1007/s00401-021-02358-4  1
2021 Katsushima K, Jallo G, Eberhart CG, Perera RJ. Long non-coding RNAs in brain tumors. Nar Cancer. 3: zcaa041. PMID 34316694 DOI: 10.1093/narcan/zcaa041  1
2021 Maxwell MJ, Arnold A, Sweeney H, Chen L, Lih TM, Schnaubelt M, Eberhart CG, Rubens JA, Zhang H, Clark DJ, Raabe EH. Unbiased proteomic and phosphoproteomic analysis identifies response signatures and novel susceptibilities after combined MEK and mTOR inhibition in BRAF mutant glioma. Molecular & Cellular Proteomics : McP. 100123. PMID 34298159 DOI: 10.1016/j.mcpro.2021.100123  1
2021 Liu T, Siadati S, Eberhart CG, Akpek E. Clinicopathologic analysis of conjunctivochalasis and paste-pinch-cut conjunctivoplasty for management. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. PMID 34192522 DOI: 10.1016/j.jcjo.2021.06.001  1
2021 Milde T, Rodriguez FJ, Barnholtz-Sloan JS, Patil N, Eberhart CG, Gutmann DH. Reimagining Pilocytic Astrocytomas in the Context of Pediatric Low-Grade Gliomas. Neuro-Oncology. PMID 34131743 DOI: 10.1093/neuonc/noab138  1
2021 Ma D, Zhan D, Fu Y, Wei S, Lal B, Wang J, Li Y, Lopez-Bertoni H, Yalcin F, Dzaye O, Eberhart CG, Laterra J, Wilson MA, Ying M, Xia S. Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1. Cancer Letters. PMID 34098063 DOI: 10.1016/j.canlet.2021.05.038  1
2021 Zhou L, Xu Z, Guerra J, Rosenberg AZ, Fenaroli P, Eberhart CG, Duh EJ. Expression of the SARS-CoV-2 Receptor ACE2 in Human Retina and Diabetes-Implications for Retinopathy. Investigative Ophthalmology & Visual Science. 62: 6. PMID 34086044 DOI: 10.1167/iovs.62.7.6  1
2021 Rooper LM, Agaimy A, Dickson BC, Dueber JC, Eberhart CG, Gagan J, Hartmann A, Khararjian A, London NR, MacMillan CM, Palsgrove DN, Nix JS, Sandison A, Stoehr R, Truong T, et al. DEK-AFF2 Carcinoma of the Sinonasal Region and Skull Base: Detailed Clinicopathologic Characterization of a Distinctive Entity. The American Journal of Surgical Pathology. PMID 34049316 DOI: 10.1097/PAS.0000000000001741  1
2021 Foster JW, Parikh RN, Wang J, Bower KS, Matthaei M, Chakravarti S, Jun AS, Eberhart CG, Soiberman US. Transcriptomic and Immunohistochemical Analysis of Progressive Keratoconus Reveal Altered WNT10A in Epithelium and Bowman's Layer. Investigative Ophthalmology & Visual Science. 62: 16. PMID 33988693 DOI: 10.1167/iovs.62.6.16  1
2021 Chang EK, Smith-Cohn MA, Tamrazi B, Ji J, Krieger M, Holdhoff M, Eberhart CG, Margol AS, Cotter JA. IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature. Brain Pathology (Zurich, Switzerland). e12959. PMID 33960568 DOI: 10.1111/bpa.12959  1
2021 Nakata S, Yuan M, Rubens JA, Kahlert UD, Maciaczyk J, Raabe EH, Eberhart CG. BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets. International Journal of Molecular Sciences. 22. PMID 33920124 DOI: 10.3390/ijms22083913  1
2021 Gao M, Fu Y, Zhou W, Gui G, Lal B, Li Y, Xia S, Ji H, Eberhart CG, Laterra J, Ying M. EGFR Activates a TAZ-driven Oncogenic Program in Glioblastoma. Cancer Research. PMID 33910930 DOI: 10.1158/0008-5472.CAN-20-2773  1
2021 Jensen AD, Hodgson NM, Parikh R, Eberhart CG, Henderson AD, Fu R. Orbital inflammation in the setting of a nylon foil implant. Orbit (Amsterdam, Netherlands). 1-4. PMID 33904346 DOI: 10.1080/01676830.2021.1918725  1
2021 Katsushima K, Lee B, Kunhiraman H, Zhong C, Murad R, Yin J, Liu B, Garancher A, Gonzalez-Gomez I, Monforte HL, Stapleton S, Vibhakar R, Bettegowda C, Wechsler-Reya RJ, Jallo G, ... ... Eberhart CG, et al. The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas. Neuro-Oncology. 23: 572-585. PMID 33844835 DOI: 10.1093/neuonc/noaa235  1
2021 Hu K, Babapoor-Farrokhran S, Rodrigues M, Deshpande M, Puchner B, Kashiwabuchi F, Hassan SJ, Asnaghi L, Handa JT, Merbs S, Eberhart CG, Semenza GL, Montaner S, Sodhi A. Correction: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma. Oncotarget. 12: 519-520. PMID 33747364 DOI: 10.18632/oncotarget.27780  1
2021 Moore RF, Zhang XR, Allison DB, Rooper LM, Campbell AA, Eberhart CG. High-Risk Human Papillomavirus and ZEB1 in Ocular Adnexal Sebaceous Carcinoma. Journal of Cutaneous Pathology. PMID 33745190 DOI: 10.1111/cup.13987  1
2021 Skowron P, Farooq H, Cavalli FMG, Morrissy AS, Ly M, Hendrikse LD, Wang EY, Djambazian H, Zhu H, Mungall KL, Trinh QM, Zheng T, Dai S, Stucklin ASG, Vladoiu MC, ... ... Eberhart CG, et al. The transcriptional landscape of Shh medulloblastoma. Nature Communications. 12: 1749. PMID 33741928 DOI: 10.1038/s41467-021-21883-0  1
2021 Xue Y, Fu Y, Zhao F, Gui G, Li Y, Rivero-Hinojosa S, Liu G, Li Y, Xia S, Eberhart CG, Ying M. Frondoside A Inhibits a MYC-driven Medulloblastoma Model Derived from Human Induced Pluripotent Stem Cells. Molecular Cancer Therapeutics. PMID 33722850 DOI: 10.1158/1535-7163.MCT-20-0603  1
2021 Pham K, Maxwell MJ, Sweeney H, Alt J, Rais R, Eberhart CG, Slusher BS, Raabe EH. Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis. Journal of Neuropathology and Experimental Neurology. PMID 33712838 DOI: 10.1093/jnen/nlab018  1
2021 Maynard R, Poore B, Hanaford AR, Pham K, James M, Alt J, Park Y, Slusher BS, Tamayo P, Mesirov J, Archer TC, Pomeroy S, Eberhart CG, Raabe EH. TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma. Cancer Letters. PMID 33571541 DOI: 10.1016/j.canlet.2021.02.001  1
2021 Rajaii F, Kim DW, Pan J, Mahoney NR, Eberhart CG, Qian J, Blackshaw S. Temperature and species-dependent regulation of browning in retrobulbar fat. Scientific Reports. 11: 3094. PMID 33542375 DOI: 10.1038/s41598-021-82672-9  1
2021 Ahmad M, Carey AR, Eberhart CG, Siadati S, Henderson AD. Peripheral retinal arteriolar leakage in giant cell arteritis: a case report. Journal of Ophthalmic Inflammation and Infection. 11: 5. PMID 33511449 DOI: 10.1186/s12348-021-00235-5  1
2020 Yuan M, White D, Resar L, Bar E, Groves M, Cohen A, Jackson E, Bynum J, Rubens J, Mumm J, Chen L, Jiang L, Raabe E, Rodriguez F, Eberhart CG. Conditional reprograming culture conditions facilitate growth of lower grade glioma models. Neuro-Oncology. PMID 33258947 DOI: 10.1093/neuonc/noaa263  1
2020 Natsumeda M, Miyahara H, Yoshimura J, Nakata S, Nozawa T, Ito J, Kanemaru Y, Watanabe J, Tsukamoto Y, Okada M, Oishi M, Hirato J, Wataya T, Ahsan S, Tateishi K, ... ... Eberhart CG, et al. GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma. Journal of Neuropathology and Experimental Neurology. PMID 33249504 DOI: 10.1093/jnen/nlaa141  1
2020 Xia S, Ding Z, Luo L, Chen B, Schneider J, Yang J, Eberhart CG, Stark WJ, Xu Q. Shear-Thinning Viscous Materials for Subconjunctival Injection of Microparticles. Aaps Pharmscitech. 22: 8. PMID 33241486 DOI: 10.1208/s12249-020-01877-9  1
2020 Milman T, Eiger-Moscovich M, Henry RK, Folberg R, Coupland SE, Grossniklaus HE, Mudhar HS, Eberhart CG, Heegaard S, Auw-Hädrich C, Herwig-Carl MC, Löffler KU, Cherepanoff S, Zhang Q, Sharpe JE, et al. Validation Of The Newly Proposed Who Classification System For Conjunctival Melanocytic Intraepithelial Lesions: A Comparison With The 'C-Min' And 'Pam' Classification Schemes. American Journal of Ophthalmology. PMID 33130046 DOI: 10.1016/j.ajo.2020.10.020  0.01
2020 Kim YC, Shin MD, Hackett SF, Hsueh HT, Lima E Silva R, Date A, Han H, Kim BJ, Xiao A, Kim Y, Ogunnaike L, Anders NM, Hemingway A, He P, Jun AS, ... ... Eberhart C, et al. Gelling hypotonic polymer solution for extended topical drug delivery to the eye. Nature Biomedical Engineering. PMID 32895514 DOI: 10.1038/S41551-020-00606-8  1
2020 Suller AL, Parikh RN, Zhao J, Mahoney NR, Campbell AA, Siadati S, Eberhart CG, Fu R. Chocolate Cysts Associated With Porous Polyethylene Orbital Implants. Ophthalmic Plastic and Reconstructive Surgery. PMID 32826826 DOI: 10.1097/Iop.0000000000001797  1
2020 Ahmad M, Chen HC, Chang JR, Hodgson N, McDonnell EC, Henderson AD, Siadati S, Eberhart CG, McCulley TJ. Tarsal Epithelial Cysts: Prevalence, Case Series, and Synthesis of Existing Literature. Ophthalmic Plastic and Reconstructive Surgery. PMID 32826823 DOI: 10.1097/Iop.0000000000001795  1
2020 Yang J, Luo L, Oh Y, Meng T, Chai G, Xia S, Emmert D, Wang B, Eberhart CG, Lee S, Stark WJ, Ensign LM, Hanes J, Xu Q. Sunitinib malate-loaded biodegradable microspheres for the prevention of corneal neovascularization in rats. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32822742 DOI: 10.1016/J.Jconrel.2020.08.019  1
2020 Arnold A, Rodriguez F, Eberhart CG, Raabe EH. Response to letter to the editor: "All models are wrong; some models are useful". Neuro-Oncology. PMID 32597469 DOI: 10.1093/Neuonc/Noaa137  1
2020 Shinde V, Hu N, Mahale A, Maiti G, Daoud Y, Eberhart CG, Maktabi A, Jun AS, Al-Swailem SA, Chakravarti S. RNA sequencing of corneas from two keratoconus patient groups identifies potential biomarkers and decreased NRF2-antioxidant responses. Scientific Reports. 10: 9907. PMID 32555404 DOI: 10.1038/S41598-020-66735-X  1
2020 Zhou L, Xu Z, Castiglione GM, Soiberman US, Eberhart CG, Duh EJ. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. The Ocular Surface. PMID 32544566 DOI: 10.1016/J.Jtos.2020.06.007  1
2020 Zhou L, Xu Z, Castiglione GM, Soiberman US, Eberhart CG, Duh EJ. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Biorxiv : the Preprint Server For Biology. PMID 32511393 DOI: 10.1101/2020.05.09.086165  1
2020 Alkatan HM, Alsalamah AK, Almizel A, Alshomar KM, Maktabi AM, ElKhamary SM, Eberhart CG, Iuliano A, Lanni V, Strianese D. Orbital solitary fibrous tumors: a multi-centered histopathological and immunohistochemical analysis with radiological description. Annals of Saudi Medicine. 40: 227-233. PMID 32493043 DOI: 10.5144/0256-4947.2020.227  1
2020 Shahab S, Rubens J, Kaur H, Sweeney H, Eberhart CG, Raabe EH. MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid Tumors. Journal of Neuropathology and Experimental Neurology. PMID 32472116 DOI: 10.1093/Jnen/Nlaa042  1
2020 Lazo de la Vega L, Bick N, Hu K, Rahrig SE, Silva CD, Matayoshi S, Picciarelli P, Wang X, Sugar A, Soong HK, Mian SI, Robinson DR, Chinnaiyan AM, Demirci H, Daniels AB, ... ... Eberhart CG, et al. Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 32461624 DOI: 10.1038/S41379-020-0571-7  0.01
2020 Agni M, Raven ML, Bowen RC, Laver NV, Chevez-Barrios P, Milman T, Eberhart CG, Couch S, Bennett DD, Albert DM, Hogan RN, Phelps PO, Stiefel H, Mancera N, Hyrcza M, et al. An Update on Endocrine Mucin-producing Sweat Gland Carcinoma: Clinicopathologic Study of 63 Cases and Comparative Analysis. The American Journal of Surgical Pathology. PMID 32452870 DOI: 10.1097/Pas.0000000000001462  1
2020 Eberhart CG, Bar EE. Spatial enrichment of cellular states in glioblastoma. Acta Neuropathologica. PMID 32449056 DOI: 10.1007/S00401-020-02165-3  1
2020 Negron K, Zhu C, Chen SW, Shahab S, Rao D, Raabe EH, Eberhart CG, Hanes J, Suk JS. Non-adhesive and highly stable biodegradable nanoparticles that provide widespread and safe transgene expression in orthotopic brain tumors. Drug Delivery and Translational Research. PMID 32323162 DOI: 10.1007/S13346-020-00759-8  1
2020 Louis DN, Wesseling P, Aldape K, Brat DJ, Capper D, Cree IA, Eberhart C, Figarella-Branger D, Fouladi M, Fuller GN, Giannini C, Haberler C, Hawkins C, Komori T, Kros JM, et al. cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathology (Zurich, Switzerland). PMID 32307792 DOI: 10.1111/Bpa.12832  1
2020 Shakarchi AF, Woreta F, Stroh IG, Eberhart CG, Vizcaino MA, Collins ME. Partial-thickness scleral defect in a congenital scleral epithelial cyst. Journal of Aapos : the Official Publication of the American Association For Pediatric Ophthalmology and Strabismus. PMID 32259584 DOI: 10.1016/J.Jaapos.2020.01.012  1
2020 Rubens J, Eberhart CG. SWI/SNF complex differences promote cellular heterogeneity in rhabdoid tumors. Neuro-Oncology. PMID 32227229 DOI: 10.1093/Neuonc/Noaa081  1
2020 Nakata S, Price A, Eberhart C, Morris M. Increased Tau Expression Correlates With IDH Mutation in Infiltrating Gliomas and Impairs Cell Migration. Journal of Neuropathology and Experimental Neurology. PMID 32181806 DOI: 10.1093/Jnen/Nlaa013  1
2020 Eberhart C. Astrocytes: new stars in the medulloblastoma firmament. Neuro-Oncology. 22: 587-589. PMID 32157298 DOI: 10.1093/Neuonc/Noaa057  0.01
2020 Yao M, Ventura PB, Jiang Y, Rodriguez FJ, Wang L, Perry JSA, Yang Y, Wahl K, Crittenden RB, Bennett ML, Qi L, Gong CC, Li XN, Barres BA, Bender TP, ... ... Eberhart CG, et al. Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth. Cell. PMID 31983537 DOI: 10.1016/J.Cell.2019.12.024  1
2020 Kaur H, Guo H, White D, Green P, Hector AM, Akhtarkhavari S, Bhargava A, Shah S, Eberhart CG, Mumm J, Raabe EH. Abstract A38: Validation of potential therapies for treatment of fatal pediatric brain tumors DIPG and AT/RT using a novel rapid intracranial model in zebrafish Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-A38  1
2020 Parkhurst A, Wang S, Kaur H, Arnold A, Eberhart C, Raabe E, Rubens J. Abstract 6226: Sapanisertib interferes with the NRF2-mediated stress response to synergize with Obatoclax and extend AT/RT survival Cancer Research. 80: 6226-6226. DOI: 10.1158/1538-7445.Am2020-6226  1
2020 Guo H, Kaur H, Eberhart CG, Raabe EH. Abstract 4943: The stem cell factor LIN28B regulates proliferation and apoptosis in diffuse intrinsic pontine glioma Cancer Research. 80: 4943-4943. DOI: 10.1158/1538-7445.Am2020-4943  1
2020 Parkhurst A, Park Y, Arnold A, Koldobskiy M, Eberhart C, Raabe E, Rubens J. Abstract 3904: The novel combination of PAC-1 and ONC201 circumvent H3K27M-driven pro-survival gene expression to induce DIPG cell death Tumor Biology. DOI: 10.1158/1538-7445.Am2020-3904  1
2019 Shifera AS, Eberhart C, Kuo IC. Role of anterior segment imaging in the diagnosis of atypical pterygium. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. PMID 31874709 DOI: 10.1016/J.Jcjo.2019.10.009  0.01
2019 Arnold A, Yuan M, Price A, Harris L, Eberhart CG, Raabe EH. Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity. Neuro-Oncology. PMID 31841591 DOI: 10.1093/Neuonc/Noz230  1
2019 Zhang M, Iyer RR, Azad TD, Wang Q, Garzon-Muvdi T, Wang J, Liu A, Burger P, Eberhart C, Rodriguez FJ, Sciubba DM, Wolinsky JP, Gokaslan Z, Groves ML, Jallo GI, et al. Genomic Landscape of Intramedullary Spinal Cord Gliomas. Scientific Reports. 9: 18722. PMID 31822682 DOI: 10.1038/S41598-019-54286-9  1
2019 Martin AM, Bell WR, Yuan M, Harris L, Poore B, Arnold A, Engle EL, Asnaghi L, Lim M, Raabe EH, Eberhart CG. PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status. Journal of Neuropathology and Experimental Neurology. PMID 31819973 DOI: 10.1093/Jnen/Nlz119  1
2019 Han D, Serra R, Gorelick N, Fatima U, Eberhart CG, Brem H, Tyler B, Steckl AJ. Multi-layered core-sheath fiber membranes for controlled drug release in the local treatment of brain tumor. Scientific Reports. 9: 17936. PMID 31784666 DOI: 10.1038/S41598-019-54283-Y  1
2019 Lafay-Cousin L, Bouffet E, Strother D, Rudneva V, Hawkins C, Eberhart C, Horbinski C, Heier L, Souweidane M, Williams-Hughes C, Onar-Thomas A, Billups CA, Fouladi M, Northcott P, Robinson G, et al. Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900845. PMID 31774708 DOI: 10.1200/Jco.19.00845  1
2019 Joshi P, Katsushima K, Zhou R, Meoded A, Stapleton S, Jallo G, Raabe E, Eberhart CG, Perera RJ. The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma. Neuro-Oncology Advances. 1: vdz023. PMID 31763623 DOI: 10.1093/noajnl/vdz023  1
2019 Suzuki H, Kumar SA, Shuai S, Diaz-Navarro A, Gutierrez-Fernandez A, De Antonellis P, Cavalli FMG, Juraschka K, Farooq H, Shibahara I, Vladoiu MC, Zhang J, Abeysundara N, Przelicki D, Skowron P, ... ... Eberhart CG, et al. Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma. Nature. 574: 707-711. PMID 31664194 DOI: 10.1038/S41586-019-1650-0  1
2019 Shinde V, Hu N, Renuse S, Mahale A, Pandey A, Eberhart C, Stone D, Al-Swailem SA, Maktabi A, Chakravarti S. Mapping Keratoconus Molecular Substrates by Multiplexed High-Resolution Proteomics of Unpooled Corneas. Omics : a Journal of Integrative Biology. PMID 31651220 DOI: 10.1089/Omi.2019.0143  1
2019 Suzuki H, Kumar SA, Shuai S, Diaz-Navarro A, Gutierrez-Fernandez A, De Antonellis P, Cavalli FMG, Juraschka K, Farooq H, Shibahara I, Vladoiu MC, Zhang J, Abeysundara N, Przelicki D, Skowron P, ... ... Eberhart CG, et al. Recurrent non-coding U1-snRNA mutations drive cryptic splicing in Shh medulloblastoma. Nature. PMID 31597162 DOI: 10.1038/s41586-019-1650-0  1
2019 You JY, Eberhart CG, Karakus S, Akpek EK. Characterization of Progressive Cicatrizing Conjunctivitis with Negative Immunofluorescence Staining. American Journal of Ophthalmology. PMID 31560878 DOI: 10.1016/J.Ajo.2019.09.020  1
2019 Vizcaino MA, Tabbarah AZ, Asnaghi L, Maktabi A, Eghrari AO, Srikumaran D, Eberhart CG, Rodriguez FJ. ADAM3A copy number gains occur in a subset of conjunctival squamous cell carcinoma and its high grade precursors. Human Pathology. PMID 31493427 DOI: 10.1016/J.Humpath.2019.08.020  1
2019 Asnaghi L, White DT, Yoon L, Price A, Lee GY, Sahoo A, Mumm JS, Eberhart CG. Downregulation of Nodal inhibits metastatic progression in retinoblastoma. Acta Neuropathologica Communications. 7: 137. PMID 31451106 DOI: 10.1186/S40478-019-0785-4  1
2019 Gruener AM, Poostchi A, Carey AR, Eberhart CG, Henderson AD, Chang JR, McCulley TJ. Association of Giant Cell Arteritis With Race. Jama Ophthalmology. PMID 31393529 DOI: 10.1001/Jamaophthalmol.2019.2919  1
2019 Hanaford AR, Alt J, Rais R, Wang SZ, Kaur H, Thorek DLJ, Eberhart CG, Slusher BS, Martin AM, Raabe EH. Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma. Translational Oncology. 12: 1314-1322. PMID 31340195 DOI: 10.1016/J.Tranon.2019.05.013  1
2019 Wang SZ, Poore B, Alt J, Price A, Allen SJ, Hanaford AR, Kaur H, Orr BA, Slusher BS, Eberhart CG, Raabe EH, Rubens JA. Unbiased metabolic profiling predicts sensitivity of high MYC-expressing atypical teratoid/rhabdoid tumors to glutamine inhibition with 6-diazo-5-oxo-L-norleucine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31300448 DOI: 10.1158/1078-0432.Ccr-19-0189  1
2019 Horbinski C, Ligon KL, Brastianos P, Huse JT, Venere M, Chang S, Buckner J, Cloughesy T, Jenkins RB, Giannini C, Nabors LB, Wen PY, Aldape KJ, Lukas RV, Galanis E, ... Eberhart CG, et al. The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients. Neuro-Oncology. PMID 31276167 DOI: 10.1093/Neuonc/Noz119  1
2019 Martínez H, Nagurney M, Wang ZX, Eberhart CG, Heaphy CM, Curtis MT, Rodriguez FJ. ATRX Mutations in Pineal Parenchymal Tumors of Intermediate Differentiation. Journal of Neuropathology and Experimental Neurology. PMID 31225581 DOI: 10.1093/Jnen/Nlz050  1
2019 Eberhart CG. A fox with many faces: FOXR2 and embryonal brain tumors. Neuro-Oncology. PMID 31149715 DOI: 10.1093/Neuonc/Noz102  0.01
2019 Yates JR, Mines MJ, Subramanian PS, Rivera-Michlig R, Cummings TJ, Eberhart CG. Periocular Histiocytoid Carcinoma: Potential Diagnostic Challenges. Ocular Oncology and Pathology. 5: 94-101. PMID 30976586 DOI: 10.1159/000490250  0.01
2019 Wang J, Merino DM, Light N, Murphy BL, Wang YD, Guo X, Hodges AP, Chau LQ, Liu KW, Dhall G, Asgharzadeh S, Kiehna EN, Shirey RJ, Janda KD, Taylor MD, ... ... Eberhart CG, et al. Myc and loss of p53 cooperate to drive formation of choroid plexus carcinoma. Cancer Research. PMID 30885981 DOI: 10.1158/0008-5472.Can-18-2565  1
2019 Schreck KC, Ranjan S, Skorupan N, Bettegowda C, Eberhart CG, Ames HM, Holdhoff M. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas. Journal of Neuro-Oncology. PMID 30864101 DOI: 10.1007/S11060-019-03134-X  1
2019 Tao R, Murad N, Xu Z, Zhang P, Okonechnikov K, Kool M, Rivero-Hinojosa S, Lazarski C, Zheng P, Liu Y, Eberhart CG, Rood BR, Packer R, Pei Y. MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. Cancer Research. PMID 30862721 DOI: 10.1158/0008-5472.Can-18-1787  1
2019 Schlein LJ, Fadl-Alla B, Pondenis HC, Lezmi S, Eberhart CG, LeBlanc AK, Dickinson PJ, Hergenrother PJ, Fan TM. Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain Cancers. Frontiers in Oncology. 9: 96. PMID 30859090 DOI: 10.3389/Fonc.2019.00096  0.01
2019 Wang B, Tang Y, Oh Y, Lamb NW, Xia S, Ding Z, Chen B, Suárez MJ, Meng T, Kulkarni V, Eberhart CG, Ensign LM, Stark WJ, Hanes J, Xu Q. Controlled release of dexamethasone sodium phosphate with biodegradable nanoparticles for preventing experimental corneal neovascularization. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 30677499 DOI: 10.1016/J.Nano.2019.01.001  1
2019 Beckmann PJ, Larson JD, Larsson AT, Ostergaard JP, Wagner S, Rahrmann EP, Shamsan GA, Otto GM, Williams RL, Wang J, Lee C, Tschida BR, Das P, Dubuc AM, Moriarity BS, ... ... Eberhart CG, et al. Sleeping Beauty insertional mutagenesis reveals important genetic drivers of central nervous system embryonal tumors. Cancer Research. PMID 30674530 DOI: 10.1158/0008-5472.Can-18-1261  1
2019 Luo L, Yang J, Oh Y, Hartsock MJ, Xia S, Kim YC, Ding Z, Meng T, Eberhart CG, Ensign L, Thorne JE, Stark WJ, Duh EJ, Xu Q, Hanes J. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30660629 DOI: 10.1016/J.Jconrel.2019.01.018  1
2019 Natsumeda M, Liu Y, Nakata S, Miyahara H, Hanaford A, Ahsan S, Stearns D, Skuli N, Kahlert UD, Raabe EH, Rodriguez FJ, Eberhart CG. Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastoma. Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 30632221 DOI: 10.1111/Neup.12534  1
2019 Maxwell MJ, Poore BA, Hanaford A, Alt J, Rais R, Slusher BS, Eberhart CG, Raabe EH. Abstract 5277: Glutamine antagonists synergize with L-asparaginase in MYCN-driven rhabdomyosarcoma Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-5277  1
2019 Wang SZ, Poore B, Alt J, Price A, Allen S, Orr B, Rais R, Slusher B, Eberhart C, Raabe EH, Rubens JH. Abstract 5267: Unbiased metabolic profiling of atypical teratoid/rhabdoid tumors predicts sensitivity to the glutamine metabolic inhibitor 6-diazo-5-oxo-L-norleucine Cancer Research. 79: 5267-5267. DOI: 10.1158/1538-7445.Sabcs18-5267  1
2019 Arnold A, Harris L, Yuan M, Rodriguez F, Eberhart C, Raabe E. Abstract 3108: Inhibition of the mTOR and MAPK pathways suppresses growth, induces apoptosis, and decreases vascularity in pediatric low grade glioma Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3108  1
2019 Kaur H, Guo H, Green P, Akhtarkhavari S, Shah S, Eberhart CG, Raabe EH. Abstract 2888: Targeting the fatal pediatric brain tumors AT/RT and DIPG with the DNA binding agent quinacrine Cancer Research. 79: 2888-2888. DOI: 10.1158/1538-7445.Sabcs18-2888  1
2019 Shahab S, Rubens J, Eberhart C, Raabe E. Abstract 3120: The novel MEK inhibitor binimetinib decreases cell growth and induces apoptosis in AT/RT Cancer Research. 79: 3120-3120. DOI: 10.1158/1538-7445.Am2019-3120  1
2019 Azad TD, Zhang M, Iyer R, Wang Q, Garzon-Muvdi T, Wang J, Liu A, Burger PC, Eberhart CG, Rodriguez FJ, Sciubba DM, Wolinsky J, Gokaslan ZL. Genomic Landscape of Intramedullary Spinal Cord Tumors Suggests Distinct Genetic Origins Compared to Intracranial Histopathologic Counterparts Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_332  0.01
2019 Sloan L, Sen R, Doucet M, Blosser L, Shpitser I, Sherman E, San N, Cheng Z, Katulis L, Wemmer J, Kamson D, Jackson C, Hu C, McNutt T, Grossman S, ... ... Eberhart C, et al. RTHP-43 (LTBK-02). MULTI-TIME POINT EVALUATION OF PERIPHERAL BLOOD MYELOID-DERIVED SUPPRESSOR CELL AND LYMPHOCYTE POPULATIONS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA RECEIVING ADJUVANT THERAPY Neuro-Oncology. 21: vi283-vi283. DOI: 10.1093/Neuonc/Noz219.1196  0.01
2019 Arnold A, Harris L, Yuan M, Rodriguez F, Eberhart C, Raabe E. PDTM-18. COMBINED SUPPRESSION OF THE mTOR AND MAPK PATHWAYS INHIBITS GROWTH, DECREASES VASCULARITY AND INDUCES APOPTOSIS OR SENESCENCE IN PEDIATRIC LOW GRADE GLIOMA Neuro-Oncology. 21: vi191-vi191. DOI: 10.1093/Neuonc/Noz175.794  0.01
2019 Katsushima K, Joshi P, Lee B, Stapleton S, Jallo G, Raabe E, Eberhart C, Perera R. GENE-09. LONG NONCODING RNA lncHLX2-7 A PUTATIVE MOLECULAR MARKER AND A THERAPEUTIC TARGET FOR GROUP III MEDULLOBLASTOMA Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.411  1
2019 Arnold A, Harris L, Yuan M, Rodriguez F, Eberhart C, Raabe E. LGG-15. COMBINED SUPPRESSION OF THE MTOR AND MAPK PATHWAYS INHIBITS CELL PROLIFERATION AND DECREASES VASCULARITY IN PEDIATRIC LOW GRADE GLIOMA Neuro-Oncology. 21: ii102-ii102. DOI: 10.1093/Neuonc/Noz036.158  0.01
2019 Martin A, Bell R, Yuan M, Harris L, Arnold A, Poore B, Asnaghi L, Raabe E, Eberhart C. LGG-09. PD-L1 EXPRESSION IN PEDIATRIC LOW GRADE GLIOMAS, AN OPPORTUNITY FOR INTERVENTION INDEPENDENT OF BRAF MUTATIONAL STATUS Neuro-Oncology. 21: ii100-ii100. DOI: 10.1093/Neuonc/Noz036.152  0.01
2019 Kaur H, Guo H, Akhtarkhavari S, Eberhart C, Raabe E. HGG-25. TARGETING THE EPIGENETIC MODIFIER HMGA2 IN DIPG AND HIGH GRADE GLIOMAS INHIBITS PROLIFERATION, INVASION AND TUMORIGENICITY Neuro-Oncology. 21: ii92-ii92. DOI: 10.1093/Neuonc/Noz036.119  0.01
2019 Shahab S, Rubens J, Eberhart C, Raabe E. ATRT-12. BINIMETINIB SUPPRESSES THE GROWTH OF ATYPICAL TERATOID/RHABDOID TUMOR CELLS AND INDUCES APOPOTOSIS Neuro-Oncology. 21: ii65-ii65. DOI: 10.1093/Neuonc/Noz036.011  0.01
2019 Wang S, Poore B, Alt J, Price A, Allen S, Orr B, Rais R, Slusher B, Eberhart C, Raabe E, Rubens J. ATRT-04. UNBIASED METABOLIC PROFILING OF ATYPICAL TERATOID/RHABDOID TUMORS PREDICTS SENSITIVITY TO GLUTAMINE METABOLIC INHIBITORS Neuro-Oncology. 21: ii63-ii63. DOI: 10.1093/Neuonc/Noz036.003  0.01
2019 Sloan L, Sen R, Doucet M, Blosser L, Shpitser I, Cheng Z, Katulis L, Wemmer J, Jackson C, Hu C, McNutt T, Grossman S, Holdhoff M, Lim M, Redmond K, ... Eberhart C, et al. The Immunodynamics of Myeloid-Derived Suppressor Cell and Monocyte Populations in the Peripheral Blood in Patients with Newly Diagnosed Glioblastoma Undergoing Adjuvant Temozolomide and Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 105: E650-E651. DOI: 10.1016/J.Ijrobp.2019.06.1029  0.01
2018 Halani SH, Yousefi S, Vega JV, Rossi MR, Zhao Z, Amrollahi F, Holder CA, Baxter-Stoltzfus A, Eschbacher J, Griffith B, Olson JJ, Jiang T, Yates JR, Eberhart CG, Poisson LM, et al. Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways. Npj Precision Oncology. 2: 24. PMID 30417117 DOI: 10.1038/s41698-018-0067-9  1
2018 Asnaghi L, White DT, Key N, Choi J, Mahale A, Alkatan H, Edward DP, Elkhamary SM, Al-Mesfer S, Maktabi A, Hurtado CG, Lee GY, Carcaboso AM, Mumm JS, Safieh LA, ... Eberhart CG, et al. ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma. Oncogene. PMID 30401983 DOI: 10.1038/S41388-018-0543-2  1
2018 Jiang S, Eberhart CG, Lim M, Heo HY, Zhang Y, Blair L, Wen Z, Holdhoff M, Lin D, Huang P, Qin H, Quiñones-Hinojosa A, Weingart J, Barker P, Pomper MG, et al. Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30366937 DOI: 10.1158/1078-0432.Ccr-18-1233  1
2018 Hodgson NM, Campbell AA, Chang JR, Vizcaino A, Eberhart C, Pearl MS, McCulley TJ. Pituitary Adenoma Apoplexy of the Orbit, Diagnosis, and Management With Presurgical Embolization. Ophthalmic Plastic and Reconstructive Surgery. PMID 30320714 DOI: 10.1097/Iop.0000000000001241  1
2018 Tantravedi S, Vesuna F, Winnard PT, Martin A, Lim M, Eberhart CG, Berlinicke C, Raabe E, van Diest PJ, Raman V. Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33. Translational Oncology. 12: 96-105. PMID 30292066 DOI: 10.1016/J.Tranon.2018.09.002  1
2018 Poore B, Yuan M, Arnold A, Price A, Alt J, Rubens JA, Slusher BS, Eberhart CG, Raabe EH. mTORC1 inhibition in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatin. Neuro-Oncology. PMID 30239952 DOI: 10.1093/Neuonc/Noy150  1
2018 Brosnan-Cashman JA, Yuan M, Graham MK, Rizzo AJ, Myers KM, Davis C, Zhang R, Esopi DM, Raabe EH, Eberhart CG, Heaphy CM, Meeker AK. ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner. Plos One. 13: e0204159. PMID 30226859 DOI: 10.1371/Journal.Pone.0204159  1
2018 Yuan M, Da Silva ACAL, Arnold A, Okeke L, Ames H, Correa-Cerro LS, Vizcaino MA, Ho CY, Eberhart CG, Rodriguez FJ. MicroRNA (miR) 125b regulates cell growth and invasion in pediatric low grade glioma. Scientific Reports. 8: 12506. PMID 30131528 DOI: 10.1038/S41598-018-30942-4  1
2018 Tso MOM, Suarez MJ, Eberhart CG. Pathologic study of early manifestations of polypoidal choroidal vasculopathy and pathogenesis of choroidal neo-vascularization. American Journal of Ophthalmology Case Reports. 11: 176-180. PMID 30128371 DOI: 10.1016/J.Ajoc.2017.10.012  1
2018 Snuderl M, Kannan K, Pfaff E, Wang S, Stafford JM, Serrano J, Heguy A, Ray K, Faustin A, Aminova O, Dolgalev I, Stapleton SL, Zagzag D, Chiriboga L, Gardner SL, ... ... Eberhart CG, et al. Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma. Nature Communications. 9: 2868. PMID 30030436 DOI: 10.1038/S41467-018-05029-3  1
2018 Cavalli FMG, Hübner JM, Sharma T, Luu B, Sill M, Zapotocky M, Mack SC, Witt H, Lin T, Shih DJH, Ho B, Santi M, Emery L, Hukin J, Dunham C, ... ... Eberhart CG, et al. Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathologica. PMID 30019219 DOI: 10.1007/S00401-018-1888-X  1
2018 Simner PJ, Miller HB, Breitweiser FP, Pinilla Monsalve G, Pardo CA, Salzberg SL, Sears C, Thomas DL, Eberhart CG, Carroll KC. Development and Optimization of Metagenomic Next-Generation Sequencing Methods for Cerebral Spinal Fluid Diagnostics. Journal of Clinical Microbiology. PMID 29976594 DOI: 10.1128/Jcm.00472-18  1
2018 Qin H, Moore RF, Ho CY, Eshleman J, Eberhart CG, Cuda J. Endocrine mucin-producing sweat gland carcinoma: A study of eleven cases with molecular analysis. Journal of Cutaneous Pathology. PMID 29943394 DOI: 10.1111/Cup.13308  1
2018 Lopez-Bertoni H, Kozielski K, Rui Y, Lal B, Vaughan H, Wilson D, Mihelson N, Eberhart C, Laterra J, Green JJ. Bioreducible polymeric nanoparticles containing multiplexed cancer stem cell-regulating miRNAs inhibit glioblastoma growth and prolong survival. Nano Letters. PMID 29927251 DOI: 10.1021/Acs.Nanolett.8B00390  1
2018 Liu TYA, Vizcaino MA, Eberhart CG, Sachdeva MM. Association of Macular and Peripheral Retinal Macro-Pseudocysts With Chronic Retinal Detachment. Jama Ophthalmology. PMID 29902288 DOI: 10.1001/Jamaophthalmol.2018.2189  1
2018 Goldberg MF, McLeod S, Tso M, Packo K, Edwards M, Bhutto IA, Baldeosingh R, Eberhart C, Weber BHF, Lutty GA. Ocular Histopathology and Immunohistochemical Analysis in the Oldest Known Individual with Autosomal Dominant Vitreoretinochoroidopathy. Ophthalmology Retina. 2: 360-378. PMID 29774302 DOI: 10.1016/J.Oret.2017.08.001  1
2018 Alkatan HM, Eberhart CG, Alshomar KM, Elkhamary SM, Maktabi AMY. Primary mesenchymal chondrosarcoma of the orbit: Histopathological report of 3 pediatric cases. Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society. 32: 69-74. PMID 29755276 DOI: 10.1016/J.Sjopt.2018.02.016  1
2018 Vizcaino MA, Joseph SS, Eberhart CG. Orbital progressive transformation of germinal centers as part of the spectrum of IgG4-related ophthalmic disease: Clinicopathologic features of three cases. Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society. 32: 56-61. PMID 29755273 DOI: 10.1016/J.Sjopt.2018.02.017  1
2018 Martin AM, Nirschl CJ, Polanczyk MJ, Bell WR, Nirschl TR, Harris-Bookman S, Phallen J, Hicks J, Martinez D, Ogurtsova A, Xu H, Sullivan LM, Meeker AK, Raabe EH, Cohen KJ, ... Eberhart CG, et al. PD-L1 expression in medulloblastoma: an evaluation by subgroup. Oncotarget. 9: 19177-19191. PMID 29721192 DOI: 10.18632/Oncotarget.24951  1
2018 Bell WR, Meeker AK, Rizzo A, Rajpara S, Rosenthal IM, Flores Bellver M, Aparicio Domingo S, Zhong X, Barber JR, Joshu CE, Canto-Soler MV, Eberhart CG, Heaphy CM. A UNIQUE TELOMERE DNA EXPANSION PHENOTYPE IN HUMAN RETINAL ROD PHOTORECEPTORS ASSOCIATED WITH AGING AND DISEASE. Brain Pathology (Zurich, Switzerland). PMID 29668072 DOI: 10.1111/Bpa.12618  1
2018 Schreck KC, Guajardo A, Lin DDM, Eberhart CG, Grossman SA. Concurrent BRAF/MEK Inhibitors in V600-Mutant High-Grade Primary Brain Tumors. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 343-347. PMID 29632053 DOI: 10.6004/Jnccn.2017.7052  1
2018 Merk DJ, Ohli J, Merk ND, Thatikonda V, Morrissy S, Schoof M, Schmid SN, Harrison L, Filser S, Ahlfeld J, Erkek S, Raithatha K, Andreska T, Weißhaar M, Launspach M, ... ... Eberhart CG, et al. Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma. Developmental Cell. PMID 29551561 DOI: 10.1016/J.Devcel.2018.02.012  1
2018 Ames HM, Rooper LM, Laterra JJ, Eberhart CG, Rodriguez FJ. INSM1 Expression Is Frequent in Primary Central Nervous System Neoplasms but Not in the Adult Brain Parenchyma. Journal of Neuropathology and Experimental Neurology. PMID 29490065 DOI: 10.1093/Jnen/Nly014  1
2018 Casaos J, Huq S, Lott T, Felder R, Choi J, Gorelick N, Peters M, Xia Y, Maxwell R, Zhao T, Ji C, Simon T, Sesen J, Scotland SJ, Kast RE, ... ... Eberhart CG, et al. Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors. Oncotarget. 9: 8054-8067. PMID 29487714 DOI: 10.18632/Oncotarget.23883  1
2018 Li G, Adams E, Eshleman JR, Eberhart CG. No BRAF V600E Mutation Identified in 28 Periocular Pyogenic Granuloma. Ophthalmic Plastic and Reconstructive Surgery. PMID 29406329 DOI: 10.1097/IOP.0000000000001075  1
2018 Li Z, Breitwieser FP, Lu J, Jun AS, Asnaghi L, Salzberg SL, Eberhart CG. Identifying Corneal Infections in Formalin-Fixed Specimens Using Next Generation Sequencing. Investigative Ophthalmology & Visual Science. 59: 280-288. PMID 29340642 DOI: 10.1167/Iovs.17-21617  1
2018 Brosnan-Cashman JA, Graham MK, Rizzo AJ, Myers K, Zhang R, Göger E, Zarinshenas R, Davis C, Yuan M, Rakheja D, Raabe EH, Eberhart CG, Heaphy CM, Meeker AK. Abstract B14: Establishment and characterization of in vitro models of alternative lengthening of telomeres (ALT) in pediatric high-grade glioma Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-B14  1
2018 Guo H, Kaur H, Akhtarkhavari S, Eberhart CG, Raabe EH. Abstract 4850: The minor groove binding agent quinacrine inhibits growth and increases apoptotic death in diffuse intrinsic pontine glioma tumor cells Cancer Research. 78: 4850-4850. DOI: 10.1158/1538-7445.Am2018-4850  1
2018 Arnold A, Yuan M, Rodriguez FJ, Eberhart CG, Raabe EH. Abstract 4629: Synergistic growth inhibitor effect on a patient derived NF1 pilocytic astrocytoma cell line with the dual mTORC1/2 inhibitor TAK228 and MEK inhibitor trametinib Cancer Research. 78: 4629-4629. DOI: 10.1158/1538-7445.Am2018-4629  1
2018 Maxwell MJ, Poore B, Hanaford A, Alt J, Rais R, Slusher BS, Eberhart CG, Raabe EH. Abstract 3521: Glutamine metabolic inhibition synergizes with L-asparaginase in MYCN-amplified neuroblastoma Cancer Research. 78: 3521-3521. DOI: 10.1158/1538-7445.Am2018-3521  1
2018 Wang SZ, Poore B, Alt J, Rais R, Allen S, Orr B, Slusher B, Eberhart C, Raabe E, Rubens J. Abstract 3519: Disrupting glutamine metabolism depletes glutathione and sensitizes atypical teratoid/rhabdoid tumor to carboplatin Cancer Research. 78: 3519-3519. DOI: 10.1158/1538-7445.Am2018-3519  1
2018 Park Y, An P, Ding D, Eberhart CG, Raabe EH. Abstract 3182: A human neural stem cell glial brain tumor model identifies the relative contribution of different oncogenic elements to malignant transformation Cancer Research. 78: 3182-3182. DOI: 10.1158/1538-7445.Am2018-3182  1
2018 Tao R, Murad N, Xu Z, Zhang P, Okonechnikov K, Kool M, Rivero-Hinojosa S, Lazarski C, Zheng P, Eberhart C, Rood B, Packer R, Pei Y. PDTM-13. OVEREXPRESSION OF MYC ALONE IS SUFFICIENT TO INITIATE GROUP 3 MEDULLOBLASTOMA Neuro-Oncology. 20: vi206-vi206. DOI: 10.1093/Neuonc/Noy148.855  0.01
2018 Arnold A, Yuan M, Rodriguez F, Eberhart C, Raabe E. PDCT-02. COMBINED INHIBITION OF MTORC1/C2 AND MEK PATHWAY IS SYNERGISTIC IN PRECLINICAL TESTING OF PEDIATRIC LOW-GRADE GLIOMA INCLUDING A NOVEL PATIENT-DERIVED NF1 PILOCYTIC ASTROCYTOMA CELL LINE Neuro-Oncology. 20: vi200-vi201. DOI: 10.1093/Neuonc/Noy148.832  0.01
2018 Natsumeda M, Miyahara H, Yoshimura J, Nakata S, Tsukamoto Y, Watanabe J, Wataya T, Eberhart C, Kakita A, Fujii Y. PATH-46. NEURONAL DIFFERENTIATION IS INDUCED BY Gli3 IN WNT- AND SHH- ACTIVATED MEDULLOBLASTOMA Neuro-Oncology. 20: vi168-vi169. DOI: 10.1093/Neuonc/Noy148.701  0.01
2018 Lopez H, Kozielski KL, Rui Y, Lal B, Vaughan H, Wilson DR, Mihelson N, Eberhart CG, Green JJ, Laterra J. CADD-04. NANOPARTICLE DELIVERY OF miRNAs TO INHIBIT GBM STEM CELLS Neuro-Oncology. 20: vi277-vi277. DOI: 10.1093/Neuonc/Noy148.1153  0.01
2018 Hanaford A, Poore B, Alt J, Slusher B, Eberhart C, Raabe E. Mbrs-61. In Vivo Metabolomics Reveals A Potent Combination Therapy For Myc-Driven Medulloblastoma Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.505  1
2018 Maynard R, Hanaford A, Poore B, Rubens J, Archer T, Tamayo P, Pomeroy S, Eberhart C, Raabe E. MBRS-30. TORC1/2 INHIBITION SENSITIZES MYC-DRIVEN MEDULLOBLASTOMA CELLS TO CARBOPLATIN CHEMOTHERAPY Neuro-Oncology. 20: i134-i135. DOI: 10.1093/Neuonc/Noy059.475  0.01
2018 Lafay-Cousin L, Robinson G, Rudneva V, Northcott P, Billups C, Onar-Thomas A, Hawkins C, Eberhart C, Horbinski C, Heier L, Souweidane M, Strother D, Fouladi M, Bouffet E, Gajjar A. MBCL-08. MOLECULAR CHARACTERIZATION OF NODULAR DESMOPLASTIC MEDULLOBLASTOMAS IN YOUNG CHILDREN TREATED ON ACNS1221. A REPORT FROM THE CHILDREN ONCOLOGY GROUP Neuro-Oncology. 20: i118-i119. DOI: 10.1093/Neuonc/Noy059.406  0.01
2018 Arnold A, Yuan M, Rodriguez F, Eberhart C, Raabe E. LGG-52. DUAL INHIBITION OF mTORC1/C2 AND MEK PATHWAY IS SYNERGISTIC IN MULTIPLE HUMAN MODELS OF PEDIATRIC LOW-GRADE GLIOMA INCLUDING A NOVEL PATIENT-DERIVED NF1 PILOCYTIC ASTROCYTOMA CELL LINE Neuro-Oncology. 20: i115-i116. DOI: 10.1093/Neuonc/Noy059.393  0.01
2018 Poore B, Yuan M, Arnold A, Price A, Alt J, Rubens J, Slusher B, Eberhart C, Raabe E. Lgg-51. Metabolic Profiling In Pediatric Low Grade Glioma Identifies Glutathione Depletion After Mtorc1 Inhibition And Validates Everolimus And Carboplatin As A Potential Combination Therapy Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.392  1
2018 von Hoff K, Haberler C, Robinson G, Sumerauer D, Cho J, Mynarek M, Hwang E, Jacobs S, de Rojas T, Perek M, Dufour C, Snuderl M, Grundy R, da Costa MJG, van Vuurden D, ... ... Eberhart C, et al. EMBR-15. DIAGNOSTIC RE-EVALUATION AND POOLED CLINICAL DATA ANALYSIS OF PATIENTS WITH PREVIOUS DIAGNOSIS OF CNS-PNET Neuro-Oncology. 20: i72-i72. DOI: 10.1093/Neuonc/Noy059.199  0.01
2018 Pietsch T, Figarella-Branger D, Giangaspero F, Gessi M, Hawkins C, Jacques T, Korshunov A, Eberhart C, Burger P, Hoff Kv, Kool M, Haberler C. Embr-12. Improved Diagnostic Algorithm For Differential Diagnostics Of Cns Embryonal Tumors (Former Cns-Pnet) By Neuropathological Re-Evaluation Of 256 Cases And Crossvalidation By Methylation Classification Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.196  1
2018 Snuderl M, Kannan K, Pfaff E, Wang S, Stafford J, Serrano J, Heguy A, Ray K, Faustin A, Aminova O, Dolgalev I, Stapleton S, Zagzag D, Chiriboga L, Gardner S, ... ... Eberhart C, et al. EMBR-02. RECURRENT HOMOZYGOUS DELETION OF DROSHA AND MICRODUPLICATION OF PDE4DIP CONTAINING THE ANCESTRAL DUF1220 DOMAIN IN PINEOBLASTOMA Neuro-Oncology. 20: i69-i69. DOI: 10.1093/Neuonc/Noy059.187  0.01
2018 Martin A, Bell R, Eberhart C, Raabe E, Koldobskiy M. DIPG-75. INTERSECTION OF EPIGENETICS AND IMMUNITY IN DIPG Neuro-Oncology. 20: i64-i64. DOI: 10.1093/Neuonc/Noy059.167  0.01
2018 Koldobskiy M, Jenkinson G, Pujadas E, Martin A, Eberhart C, Goutsias J, Raabe E, Feinberg A. DIPG-74. DNA METHYLATION STOCHASTICITY IN DIPG Neuro-Oncology. 20: i64-i64. DOI: 10.1093/Neuonc/Noy059.166  0.01
2018 Shah S, Rubens J, Eberhart C, Raabe E. DIPG-62. CARBOPLATIN SYNERGIZES WITH BCL-2 INHIBITOR TO POTENTIATE KILLING OF DIPG CELLS Neuro-Oncology. 20: i61-i61. DOI: 10.1093/Neuonc/Noy059.155  0.01
2018 Shah S, Rubens J, Eberhart C, Raabe E. DIPG-61. HISTONE DEACETYLASE INHIBITOR PANOBINOSTAT SYNERGIZES WITH DUAL MTOR INHIBITOR TAK228 TO POTENTIATE KILLING OF DIPG CELLS Neuro-Oncology. 20: i61-i61. DOI: 10.1093/Neuonc/Noy059.154  0.01
2018 Park Y, An P, Ding D, Eberhart CG, Raabe EH. DIPG-34. A HUMAN NEURAL STEM CELL DIPG MODEL IDENTIFIES THE RELATIVE CONTRIBUTION OF DIFFERENT ONCOGENIC ELEMENTS TO INVASIVE MALIGNANT TRANSFORMATION Neuro-Oncology. 20: i55-i56. DOI: 10.1093/Neuonc/Noy059.127  0.01
2018 Rubens J, Wang S, Sharma S, Shah S, Warren K, Eberhart C, Raabe E. ATRT-38. TAK228 COMBINES WITH NAVITOCLAX TO ENHANCE PLATINUM-INDUCED CYTOTOXICITY IN AT/RT Neuro-Oncology. 20: i36-i36. DOI: 10.1093/Neuonc/Noy059.035  0.01
2018 Shahab S, Rubens J, Eberhart C, Raabe E. ATRT-37. TARGETING ATYPICAL TERATOID/RHABDOID TUMOR USING MATURE LET-7 LEADS TO INCREASED APOPTOSIS Neuro-Oncology. 20: i35-i36. DOI: 10.1093/Neuonc/Noy059.034  0.01
2018 Kaur H, Guo H, Shah S, Akhtarkhavari S, Eberhart C, Raabe E. ATRT-33. TARGETING THE LETHAL PEDIATRIC TUMORS ATRT AND DIPG WITH THE DNA MINOR-GROOVE BINDING AGENT QUINACRINE Neuro-Oncology. 20: i34-i35. DOI: 10.1093/Neuonc/Noy059.030  0.01
2018 Sajesh B, Ngoc O, Omar R, Fediuk H, Li L, Alrushaid S, Wang W, Pu J, Sun H, Siahaan T, Werbowetski-Ogilvie T, Wölfl M, Remke M, Ramaswamy V, Taylor M, ... Eberhart C, et al. 18 Peroxiredoxin1 is a therapeutic target in group-3 medulloblastoma Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 45: S16-S16. DOI: 10.1017/cjn.2018.304  0.01
2017 Vizcaino MA, Eberhart CG, Rodriguez FJ. Hemophagocytic Lymphohistiocytosis in Adults with Intraocular Involvement: Clinicopathologic Features of 3 Cases. Ocular Oncology and Pathology. 4: 1-11. PMID 29344491 DOI: 10.1159/000475551  1
2017 Jiang S, Rui Q, Wang Y, Heo HY, Zou T, Yu H, Zhang Y, Wang X, Du Y, Wen X, Chen F, Wang J, Eberhart CG, Zhou J, Wen Z. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics. European Radiology. PMID 29234914 DOI: 10.1007/S00330-017-5182-4  1
2017 Hu J, Dziumbla S, Lin J, Bibli SI, Zukunft S, de Mos J, Awwad K, Frömel T, Jungmann A, Devraj K, Cheng Z, Wang L, Fauser S, Eberhart CG, Sodhi A, et al. Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy. Nature. 552: 248-252. PMID 29211719 DOI: 10.1038/Nature25013  1
2017 Wu CC, Hou S, Orr BA, Kuo BR, Youn YH, Ong T, Roth F, Eberhart CG, Robinson GW, Solecki DJ, Taketo MM, Gilbertson RJ, Roussel MF, Han YG. mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma. Developmental Cell. PMID 29103956 DOI: 10.1016/J.Devcel.2017.10.011  1
2017 Mangraviti A, Raghavan T, Volpin F, Skuli N, Gullotti D, Zhou J, Asnaghi L, Sankey E, Liu A, Wang Y, Lee DH, Gorelick N, Serra R, Peters M, Schriefer D, ... ... Eberhart CG, et al. HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy. Scientific Reports. 7: 14978. PMID 29097800 DOI: 10.1038/S41598-017-14990-W  1
2017 Semenkow S, Li S, Kahlert UD, Raabe EH, Xu J, Arnold A, Janowski M, Oh BC, Brandacher G, Bulte JWM, Eberhart CG, Walczak P. An immunocompetent mouse model of human glioblastoma. Oncotarget. 8: 61072-61082. PMID 28977847 DOI: 10.18632/Oncotarget.17851  1
2017 Zhang C, Mastorakos P, Sobral M, Berry S, Song E, Nance E, Eberhart CG, Hanes J, Suk JS. Strategies to enhance the distribution of nanotherapeutics in the brain. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28739449 DOI: 10.1016/J.Jconrel.2017.07.028  1
2017 Kaunitz GJ, Cottrell TR, Lilo M, Muthappan V, Esandrio J, Berry S, Xu H, Ogurtsova A, Anders RA, Fischer AH, Kraft S, Gerstenblith MR, Thompson CL, Honda K, Cuda JD, ... Eberhart CG, et al. Melanoma subtypes demonstrate distinct PD-L1 expression profiles. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 28737763 DOI: 10.1038/Labinvest.2017.64  1
2017 Jiang S, Zou T, Eberhart CG, Villalobos MAV, Heo HY, Zhang Y, Wang Y, Wang X, Yu H, Du Y, van Zijl PCM, Wen Z, Zhou J. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI. Magnetic Resonance in Medicine. PMID 28714279 DOI: 10.1002/Mrm.26820  1
2017 Jiang S, Eberhart CG, Zhang Y, Heo HY, Wen Z, Blair L, Qin H, Lim M, Quinones-Hinojosa A, Weingart JD, Barker PB, Pomper MG, Laterra J, van Zijl PCM, Blakeley JO, et al. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas. European Journal of Cancer (Oxford, England : 1990). 83: 9-18. PMID 28704644 DOI: 10.1016/J.Ejca.2017.06.009  1
2017 Yang Q, Tripathy A, Yu W, Eberhart CG, Asnaghi L. Hypoxia inhibits growth, proliferation, and increases response to chemotherapy in retinoblastoma cells. Experimental Eye Research. PMID 28689747 DOI: 10.1016/J.Exer.2017.07.001  1
2017 Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, ... ... Eberhart CG, et al. Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 31: 737-754.e6. PMID 28609654 DOI: 10.1016/J.Ccell.2017.05.005  0.04
2017 Rubens JA, Wang SZ, Price A, Weingart MF, Allen SJ, Orr BA, Eberhart CG, Raabe EH. The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity. Neuro-Oncology. PMID 28582547 DOI: 10.1093/Neuonc/Nox067  1
2017 Semenkow S, Li S, Kahlert UD, Raabe EH, Xu J, Arnold A, Janowski M, Oh BC, Brandacher G, Bulte JWM, Eberhart CG, Walczak P. An immunocompetent mouse model of human glioblastoma. Oncotarget. PMID 28574813 DOI: 10.18632/oncotarget.17851  1
2017 Miyahara H, Yadavilli S, Natsumeda M, Rubens J, Rodgers L, Kambhampati M, Taylor I, Kaur H, Asnaghi L, Eberhart CG, Warren KE, Nazarian J, Raabe EH. The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma. Cancer Letters. PMID 28450157 DOI: 10.1016/J.Canlet.2017.04.019  1
2017 Zhang C, Nance EA, Mastorakos P, Chisholm J, Berry S, Eberhart C, Tyler B, Brem H, Suk JS, Hanes J. Convection enhanced delivery of cisplatin-loaded brain penetrating nanoparticles cures malignant glioma in rats. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28279797 DOI: 10.1016/J.Jconrel.2017.03.007  1
2017 Wu N, Jia D, Bates B, Basom R, Eberhart CG, MacPherson D. A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence. The Journal of Clinical Investigation. PMID 28165337 DOI: 10.1172/JCI88508  0.01
2017 Qin H, Janowski M, Pearl MS, Malysz-Cymborska I, Li S, Eberhart CG, Walczak P. Rabbit Model of Human Gliomas: Implications for Intra-Arterial Drug Delivery. Plos One. 12: e0169656. PMID 28103265 DOI: 10.1371/Journal.Pone.0169656  1
2017 Annadanam A, Vizcaino MA, Eberhart CG, Khurshid GS, Gupta P. Long standing exophytic conjunctival papilloma infected with human papillomavirus Journal of Eye and Ophthalmology. 4: 1. DOI: 10.7243/2055-2408-4-1  0.01
2017 Lafay-Cousin L, Bouffet E, Onar-Thomas A, Billups CA, Hawkins C, Eberhart C, Horbinski C, Robinson GW, Strother DR, Heier L, Souweidane MM, Fouladi M, Gajjar AJ. ACNS1221: A phase II study for the treatment of non metastatic desmoplastic medulloblastoma in children less than 4 years of age—A report from the Children Oncology Group. Journal of Clinical Oncology. 35: 10505-10505. DOI: 10.1200/Jco.2017.35.15_Suppl.10505  1
2017 Arnold A, Rodriguez F, Eberhart CG, Raabe EH. Abstract 703: Combinatory treatment for pediatric low grade glioma with the dual mTORC1/2 inhibitor TAK228 and MEK inhibitor Trametinib Cancer Research. 77: 703-703. DOI: 10.1158/1538-7445.Am2017-703  1
2017 Wang S, Rubens J, Allen S, Orr B, Eberhart C, Raabe E. Abstract 5182: Targeting abnormal metabolism downstream of MYC in atypical teratoid/rhabdoid tumors Cancer Research. 77: 5182-5182. DOI: 10.1158/1538-7445.Am2017-5182  1
2017 Guo H, Akhtarkhavari S, Eberhart CG, Kaur H, Raabe EH. Abstract 3868: The stem cell factor LIN28B regulates proliferation and apoptosis in diffuse intrinsic pontine glioma Cancer Research. 77: 3868-3868. DOI: 10.1158/1538-7445.Am2017-3868  1
2017 Kaur H, Ali SZ, Guo H, Akhtarkhavari S, Rodriguez F, Eberhart CG, Raabe EH. Abstract 3865: Targeting the epigenetic modifier HMGA2 in lethal adult and pediatric gliomas inhibits invasion, growth and tumorigenicity Cancer Research. 77: 3865-3865. DOI: 10.1158/1538-7445.Am2017-3865  1
2017 Hanaford AR, Poore B, Eberhart CG, Raabe EH. Abstract 3560: 6-diazo-5-oxo-norleucine resistant MYC-driven medulloblastoma tumors are sensitive to inhibition of glutaminase suggesting a possible glutaminase-independent mechanism of resistance Cancer Research. 77: 3560-3560. DOI: 10.1158/1538-7445.Am2017-3560  1
2017 Poore BA, Taylor I, Rubens J, Hanaford A, Maxwell M, Eberhart C, Raabe E. Abstract 3549: C-MYC sensitizes GBM with primitive features to glutamine metabolism disruption Cancer Research. 77: 3549-3549. DOI: 10.1158/1538-7445.Am2017-3549  1
2017 Brosnan-Cashman JA, Rizzo AJ, Goger E, Myers KM, Zarinshenas R, Davis C, Yuan M, Rakheja D, Raabe EH, Eberhart CG, Heaphy CM, Meeker AK. Abstract 3466: ALT-positive pediatric high grade glioma cells display chemosensitivity to ATR pathway inhibition Cancer Research. 77: 3466-3466. DOI: 10.1158/1538-7445.Am2017-3466  1
2017 Brosnan-Cashman JA, Yuan M, Rizzo AJ, Myers KM, Barry WT, Davis C, Esopi DM, Rakheja D, Raabe EH, Eberhart CG, Heaphy CM, Meeker AK. Abstract 3465: Context-dependent effects of ATRX loss on telomere biology in glioma cells Cancer Research. 77: 3465-3465. DOI: 10.1158/1538-7445.Am2017-3465  1
2017 Xu Q, Wang K, Ahsan S, Rodriguez F, Eberhart C, Jiang Y, Laterra J, Li Y. Abstract 1471: miR-148a-3p regulation of OTX2 and PRC2 in group 3 and 4 medulloblastoma Cancer Research. 77: 1471-1471. DOI: 10.1158/1538-7445.Am2017-1471  1
2017 Natsumeda M, Miyahara H, Yoshimura J, Nozawa T, Tsukamoto Y, Wataya T, Eberhart C, Takahashi H, Kakita A, Fujii Y. PATH-54. Gli3 INDUCES NEURONAL DIFFERENTIATION IN WNT- AND SHH- ACTIVATED MEDULLOBLASTOMA Neuro-Oncology. 19: vi183-vi183. DOI: 10.1093/Neuonc/Nox168.743  0.01
2017 Hanaford A, Eberhart C, Raabe E. TRTH-34. NOVEL ORAL PRODRUGS OF 6-DIAZO-5-OXO NORLEUCINE IMPROVE BRAIN PENETRATION AND DEMONSTRATE EFFICACY AGAINST MYC-DRIVEN ORTHOTOPIC MEDULLOBLASTOMA XENOGRAFTS Neuro-Oncology. 19: iv59-iv59. DOI: 10.1093/Neuonc/Nox083.244  0.01
2017 Sajesh B, Omar R, Jarmasz J, Stirton H, Morrison L, Wang W, Pu J, Sun H, Bigio MD, Werbowetski-Ogilvie T, Wolfl M, Remke M, Taylor M, Eberhart C, Symons M, et al. MEDU-47. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMAS Neuro-Oncology. 19: iv47-iv47. DOI: 10.1093/Neuonc/Nox083.196  0.01
2017 Arnold A, Rodriguez F, Eberhart C, Raabe E. LGG-13. SYNERGISTIC TREATMENT FOR PEDIATRIC LOW GRADE GLIOMA WITH THE DUAL MTORC1/2 INHIBITOR TAK-228 AND MEK INHIBITOR TRAMETINIB Neuro-Oncology. 19: iv35-iv36. DOI: 10.1093/Neuonc/Nox083.146  0.01
2017 Rubens J, Wang S, Price A, Allen S, Orr B, Eberhart C, Raabe E. ATRT-08. TARGETING GLUTAMINE METABOLISM IN MYC DRIVEN ATYPICAL TERATOID RHABDOID TUMORS Neuro-Oncology. 19: iv2-iv3. DOI: 10.1093/Neuonc/Nox083.007  0.01
2016 Holdhoff M, Guner G, Rodriguez FJ, Hicks JL, Zheng Q, Forman MS, Ye X, Grossman SA, Meeker AK, Heaphy CM, Eberhart CG, De Marzo AM, Arav-Boger R. Absence of cytomegalovirus in glioblastoma and other high-grade gliomas by real-time PCR, immunohistochemistry and in situ hybridization. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28034905 DOI: 10.1158/1078-0432.Ccr-16-1490  1
2016 Asnaghi L, Tripathy A, Yang Q, Kaur H, Hanaford A, Yu W, Eberhart CG. Targeting Notch signaling as a novel therapy for retinoblastoma. Oncotarget. PMID 27661116 DOI: 10.18632/Oncotarget.12142  1
2016 AlWadani S, Suarez MJ, Kass JJ, MacQuaid E, Edward DP, Alkatan H, Eberhart C. Subepidermal Calcified Nodules of the Eyelid Differ in Children and Adults. Ophthalmic Plastic and Reconstructive Surgery. PMID 27479867 DOI: 10.1097/Iop.0000000000000778  1
2016 Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DT, Luu B, Cavalli FM, Aldape K, Remke M, Mynarek M, Rutkowski S, Gururangan S, McLendon RE, ... ... Eberhart CG, et al. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27269943 DOI: 10.1200/Jco.2015.65.7825  1
2016 Kaur H, Ali SZ, Huey L, Hütt-Cabezas M, Taylor I, Mao XG, Weingart M, Chu Q, Rodriguez FJ, Eberhart CG, Raabe EH. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma. Cancer Letters. PMID 27102002 DOI: 10.1016/J.Canlet.2016.04.020  1
2016 Binder ZA, Wilson KM, Salmasi V, Orr BA, Eberhart CG, Siu IM, Lim M, Weingart JD, Quinones-Hinojosa A, Bettegowda C, Kassam AB, Olivi A, Brem H, Riggins GJ, Gallia GL. Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines. Plos One. 11: e0150271. PMID 27028405 DOI: 10.1371/Journal.Pone.0150271  1
2016 Eberhart C. Multiple cilia suppress tumour formation. Nature Cell Biology. 18: 368-9. PMID 27027488 DOI: 10.1038/Ncb3331  0.01
2016 Mahale A, Alkatan H, Alwadani S, Othman M, Suarez MJ, Price A, Al-Hussain H, Jastaneiah S, Yu W, Maktabi A, Deepak EP, Eberhart CG, Asnaghi L. Altered gene expression in conjunctival squamous cell carcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 26916071 DOI: 10.1038/Modpathol.2016.41  1
2016 Sahm F, Jakobiec FA, Meyer J, Schrimpf D, Eberhart CG, Hovestadt V, Capper D, Lambo S, Ryzhova M, Schüller U, Zheludkova O, Kumirova E, Lichter P, von Deimling A, Jones DT, et al. Somatic mutations of DICER1 and KMT2D are frequent in intraocular medulloepitheliomas. Genes, Chromosomes & Cancer. PMID 26841698 DOI: 10.1002/Gcc.22344  1
2016 Bandopadhayay P, Ramkissoon LA, Jain P, Bergthold G, Wala J, Zeid R, Schumacher SE, Urbanski L, O'Rourke R, Gibson WJ, Pelton K, Ramkissoon SH, Han HJ, Zhu Y, Choudhari N, ... Eberhart C, et al. MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nature Genetics. PMID 26829751 DOI: 10.1038/Ng.3500  1
2016 Hu K, Babapoor-Farrokhran S, Rodrigues M, Deshpande M, Puchner B, Kashiwabuchi F, Hassan SJ, Asnaghi L, Handa JT, Merbs S, Eberhart CG, Semenza GL, Montaner S, Sodhi A. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma. Oncotarget. PMID 26761211 DOI: 10.18632/Oncotarget.6868  1
2016 Ahsan S, Haffner M, Eberhart C, Raabe E. Abstract 4440: Diffuse intrinsic pontine glioma epigenetic marks change depending on cell culture conditions: Implications for investigating epigenetically directed therapy Cancer Research. 76: 4440-4440. DOI: 10.1158/1538-7445.Am2016-4440  1
2016 Hanaford AR, Archer TC, Price A, Kahlert U, Maciaczyk J, Guido N, Kim W, Ehrenberger T, Clemons P, Dancik V, Seashore-Ludlow B, Viswanathan V, Stewart M, Rees M, Shamji A, ... ... Eberhart CG, et al. Abstract 2476: DiSCoVERing innovative therapies for rare tumors: Combining genetically accurate disease models with advanced in silico analysis to identify novel therapeutic targets Cancer Research. 76: 2476-2476. DOI: 10.1158/1538-7445.Am2016-2476  1
2016 Kaur H, Hütt-Cabezas M, Taylor I, Weingart M, Rodriguez F, Eberhart CG, Raabe EH. Abstract 2464: Disrupting the epigenetic modifier HMGA2 in DIPG and GBM inhibits tumor invasion, growth and tumorigenicity Cancer Research. 76: 2464-2464. DOI: 10.1158/1538-7445.Am2016-2464  1
2016 Rubens J, Price A, Orr B, Eberhart C, Raabe E. Abstract 2102: Targeting mTOR downstream of LIN28 in atypical teratoid rhabdoid tumors promotes apoptosis and suppresses tumorigenicity Cancer Research. 76: 2102-2102. DOI: 10.1158/1538-7445.Am2016-2102  1
2016 Kaur H, Hütt-Cabezas M, Taylor I, Weingart M, Rodriguez F, Eberhart C, Raabe E. PDTB-11. DISRUPTING THE EPIGENETIC MODIFIER HMGA2 IN LETHAL PEDIATRIC AND ADULT GLIOMAS INHIBITS INVASION, GROWTH AND TUMORIGENICITY Neuro-Oncology. 18: vi152-vi152. DOI: 10.1093/Neuonc/Now212.631  0.01
2016 Hanaford A, Archer T, Price A, Kahlert U, Maciaczyk J, Nikkhah G, Kim JW, Ehrenberger T, Clemons PA, Dančík V, Seashore-Ludlow B, Viswanathan V, Stewart ML, Rees MG, Shamji A, ... ... Eberhart C, et al. MB-103DiSCoVERing INNOVATIVE THERAPIES: COMBINING GENETICALLY ACCURATE DISEASE MODELS OF MEDULLOBLASTOMA WITH ADVANCED IN SILICO ANALYSIS TO IDENTIFY NOVEL THERAPEUTIC TARGETS Neuro-Oncology. 18: iii120.3-iii120. DOI: 10.1093/Neuonc/Now076.98  0.01
2016 Bergthold G, Bandopadhayay P, Ramkissoon L, Jain P, Wala J, Schumacher S, Ramkissoon S, Varlet P, Pages M, Ducar M, Van Hummelen P, Bowers D, Giannini C, Puget S, Hawkins C, ... ... Eberhart C, et al. LG-02MYB-QKI REARRANGEMENTS IN ANGIOCENTRIC GLIOMA DRIVE TUMORIGENICITY THROUGH A TRIPARTITE MECHANISM Neuro-Oncology. 18: iii78.2-iii78. DOI: 10.1093/Neuonc/Now075.02  0.01
2016 Ahsan S, Haffner M, Miyahara H, Natsumeda M, Liu Y, Rocco L, Eberhart C, Raabe E. HG-69CELL CULTURE CONDITIONS AFFECT DIFFUSE INTRINSIC PONTINE GLIOMA EPIGENETICS AND RESPONSE TO THERAPEUTIC AGENTS Neuro-Oncology. 18: iii64.1-iii64. DOI: 10.1093/Neuonc/Now073.65  0.01
2016 Rubens J, Price A, Eberhart C, Raabe E. AT-14mTOR INHIBITION BLOCKS A KEY LIN28 DOWNSTREAM TARGET AND ENHANCES CISPLATIN MEDIATED CYTOTOXICITY LEADING TO EXTENDED SURVIVAL IN ATYPICAL TERATOID RHABDOID TUMORS Neuro-Oncology. 18: iii4.2-iii4. DOI: 10.1093/Neuonc/Now065.13  0.01
2015 Bell WR, Singh K, Rajan Kd A, Eberhart CG. Expression of p16 and p53 in Intraepithelial Periocular Sebaceous Carcinoma. Ocular Oncology and Pathology. 2: 71-5. PMID 27171611 DOI: 10.1159/000439308  1
2015 Natsumeda M, Maitani K, Liu Y, Miyahara H, Kaur H, Chu Q, Zhang H, Kahlert U, Eberhart CG. Targeting Notch Signaling and Autophagy Increases Cytotoxicity in Glioblastoma Neurospheres. Brain Pathology (Zurich, Switzerland). PMID 26613556 DOI: 10.1111/Bpa.12343  1
2015 Jenkins NC, Rao G, Eberhart CG, Pedone CA, Dubuc AM, Fults DW. Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice. Journal of Neuro-Oncology. PMID 26518543 DOI: 10.1007/S11060-015-1985-9  1
2015 Dietrich U, Koch K, Suwala AK, Hartmann R, Cheng M, Maciaczyk D, Willbold D, Eberhart CG, Glunde K, Maciaczyk J. The effect of neurosphere culture conditions on the cellular metabolism of glioma cells. Folia Neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences. 53: 219-25. PMID 26443312 DOI: 10.5114/Fn.2015.54422  1
2015 Kahlert UD, Cheng M, Koch K, Marchionni L, Fan X, Raabe EH, Maciaczyk J, Glunde K, Eberhart CG. Alterations in Cellular Metabolome after Pharmacological Inhibition of Notch in Glioblastoma Cells. International Journal of Cancer. Journal International Du Cancer. PMID 26422827 DOI: 10.1002/Ijc.29873  1
2015 Nagel MA, White T, Khmeleva N, Rempel A, Boyer PJ, Bennett JL, Haller A, Lear-Kaul K, Kandasmy B, Amato M, Wood E, Durairaj V, Fogt F, Tamhankar MA, Grossniklaus HE, ... ... Eberhart CG, et al. Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis. Jama Neurology. 1-7. PMID 26349037 DOI: 10.1001/Jamaneurol.2015.2101  1
2015 Asnaghi L, Gezgin G, Tripathy A, Handa JT, Merbs SL, van der Velden PA, Jager MJ, Harbour JW, Eberhart CG. EMT-associated factors promote invasive properties of uveal melanoma cells. Molecular Vision. 21: 919-29. PMID 26321866  1
2015 Kahlert UD, Suwala AK, Koch K, Natsumeda M, Orr BA, Hayashi M, Maciaczyk J, Eberhart CG. Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells. Journal of Neuropathology and Experimental Neurology. 74: 889-900. PMID 26222502 DOI: 10.1097/Nen.0000000000000227  1
2015 Vizcaíno MA, Shah S, Eberhart CG, Rodriguez FJ. Clinicopathologic implications of NF1 gene alterations in diffuse gliomas. Human Pathology. PMID 26190195 DOI: 10.1016/J.Humpath.2015.05.014  1
2015 Korshunov A, Jakobiec FA, Eberhart CG, Hovestadt V, Capper D, Jones DT, Sturm D, Stagner AM, Edward DP, Eagle RC, Proia AD, Koch A, Ryzhova M, Ektova A, Schüller U, et al. Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities. Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 26183384 DOI: 10.1111/Neup.12227  1
2015 Taylor IC, Hütt-Cabezas M, Brandt WD, Kambhampati M, Nazarian J, Chang HT, Warren KE, Eberhart CG, Raabe EH. Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition. Journal of Neuropathology and Experimental Neurology. PMID 26115193 DOI: 10.1097/Nen.0000000000000216  1
2015 Eghrari AO, Gibas C, Watkins T, Vahedi S, Lee R, Houle E, Suarez MJ, Eberhart C, Sutton DA, Wiederhold NP, Sikder S, Zhang SX. First Human Case of Fungal Keratitis Caused by a Putatively Novel Species of Lophotrichus. Journal of Clinical Microbiology. PMID 26109445 DOI: 10.1128/Jcm.00471-15  1
2015 Oliver V, Jaffe AE, Song J, Wang G, Zhang P, Branham KE, Swaroop A, Eberhart CG, Zack DJ, Qian J, Merbs SL. Differential DNA Methylation Identified in the Blood and Retina of AMD Patients. Epigenetics : Official Journal of the Dna Methylation Society. 0. PMID 26067391 DOI: 10.1080/15592294.2015.1060388  1
2015 Chang JR, Baharestani S, Salek SS, Piluek WJ, Eberhart CG, McCulley TJ. Delayed Superficial Migration of Retained Hyaluronic Acid Years Following Periocular Injection. Ophthalmic Plastic and Reconstructive Surgery. PMID 25902386 DOI: 10.1097/Iop.0000000000000434  1
2015 Salvucci O, Ohnuki H, Maric D, Hou X, Li X, Yoon SO, Segarra M, Eberhart CG, Acker-Palmer A, Tosato G. EphrinB2 controls vessel pruning through STAT1-JNK3 signalling. Nature Communications. 6: 6576. PMID 25807892 DOI: 10.1038/Ncomms7576  1
2015 Edward DP, Alkatan H, Rafiq Q, Eberhart C, Al Mesfer S, Ghazi N, Al Safieh L, Kondkar AA, Abu Amero KK. MicroRNA profiling in intraocular medulloepitheliomas. Plos One. 10: e0121706. PMID 25807141 DOI: 10.1371/Journal.Pone.0121706  1
2015 Mastorakos P, Zhang C, Berry S, Oh Y, Lee S, Eberhart CG, Woodworth GF, Suk JS, Hanes J. Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain. Advanced Healthcare Materials. 4: 1023-33. PMID 25761435 DOI: 10.1002/Adhm.201400800  1
2015 Gilden D, White T, Khmeleva N, Heintzman A, Choe A, Boyer PJ, Grose C, Carpenter JE, Rempel A, Bos N, Kandasamy B, Lear-Kaul K, Holmes DB, Bennett JL, Cohrs RJ, ... ... Eberhart CG, et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology. 84: 1948-55. PMID 25695965 DOI: 10.1212/Wnl.0000000000001409  1
2015 Wang X, Dubuc AM, Ramaswamy V, Mack S, Gendoo DM, Remke M, Wu X, Garzia L, Luu B, Cavalli F, Peacock J, López B, Skowron P, Zagzag D, Lyden D, ... Eberhart C, et al. Medulloblastoma subgroups remain stable across primary and metastatic compartments. Acta Neuropathologica. 129: 449-57. PMID 25689980 DOI: 10.1007/S00401-015-1389-0  1
2015 Weingart MF, Roth JJ, Hutt-Cabezas M, Busse TM, Kaur H, Price A, Maynard R, Rubens J, Taylor I, Mao XG, Xu J, Kuwahara Y, Allen SJ, Erdreich-Epstein A, Weissman BE, ... ... Eberhart CG, et al. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target. Oncotarget. 6: 3165-77. PMID 25638158 DOI: 10.18632/Oncotarget.3078  1
2015 Pan Q, Xu Q, Boylan NJ, Lamb NW, Emmert DG, Yang JC, Tang L, Heflin T, Alwadani S, Eberhart CG, Stark WJ, Hanes J. Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats. Journal of Controlled Release : Official Journal of the Controlled Release Society. 201: 32-40. PMID 25576786 DOI: 10.1016/J.Jconrel.2015.01.009  1
2015 Kaur H, Hütt-Cabezas M, Weingart MF, Xu J, Kuwahara Y, Erdreich-Epstein A, Weissman BE, Eberhart CG, Raabe EH. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity. Journal of Neuropathology and Experimental Neurology. 74: 177-85. PMID 25575139 DOI: 10.1097/Nen.0000000000000161  1
2015 Brandt WD, Schreck KC, Bar EE, Taylor I, Marchionni L, Raabe E, Eberhart CG, Rodriguez FJ. Notch signaling activation in pediatric low-grade astrocytoma. Journal of Neuropathology and Experimental Neurology. 74: 121-31. PMID 25575134 DOI: 10.1097/Nen.0000000000000155  1
2015 Lim KJ, Brandt WD, Heth JA, Muraszko KM, Fan X, Bar EE, Eberhart CG. Lateral inhibition of Notch signaling in neoplastic cells. Oncotarget. 6: 1666-77. PMID 25557173 DOI: 10.18632/Oncotarget.2762  1
2015 Borodovsky A, Meeker AK, Kirkness EF, Zhao Q, Eberhart CG, Gallia GL, Riggins GJ. A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telomeres. Journal of Neuro-Oncology. 121: 479-87. PMID 25471051 DOI: 10.1007/S11060-014-1672-2  1
2015 Orr BA, Eberhart CG. Molecular pathways: not a simple tube--the many functions of blood vessels. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 18-23. PMID 25074609 DOI: 10.1158/1078-0432.Ccr-13-1641  1
2015 Ho CY, Mosier S, Safneck J, Salomao DR, Miller NR, Eberhart CG, Gocke CD, Batista DA, Rodriguez FJ. Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma. Brain Pathology (Zurich, Switzerland). 25: 193-201. PMID 24773246 DOI: 10.1111/Bpa.12150  1
2015 Ostheimer TA, Dunn JP, Eberhart CG, Burkholder BM. Intraocular tuberculosis presenting as a large anterior chamber mass. Ocular Immunology and Inflammation. 23: 100-1. PMID 24766656 DOI: 10.3109/09273948.2014.907434  1
2015 Lin A. Role of nestin in glioma invasion World Journal of Translational Medicine. 4: 78. DOI: 10.5528/WJTM.V4.I3.78  0.01
2015 Tok S, Neidert MC, Sharab M, Siu I, Reyes JP, Charubhumi V, Wicks RT, Eberhart C, Jallo GI, Tyler BM. Ferromagnetic Dissection in a Rat Glioma Model Journal of Cancer Therapy. 6: 613-621. DOI: 10.4236/Jct.2015.67067  0.01
2015 Snuderl M, Kannan K, Aminova O, Dolgalev I, Heguy A, Faustin A, Zagzag D, Gardner SL, Allen JC, Wisoff JH, Capper D, Hovestadt V, Ahsan S, Eberhart C, Pfister SM, et al. Abstract LB-172: Novel candidate oncogenic drivers in pineoblastoma Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-172  1
2015 Hanaford A, Guerra C, Eberhart C, Raabe E, Price A. Abstract 504: Glutamine metabolic inhibitors suppress growth and tumorigenicity in MYC and MYCN-driven pediatric malignancies Cancer Research. 75: 504-504. DOI: 10.1158/1538-7445.Am2015-504  1
2015 Taylor I, Ahsan S, Price A, Eberhart C, Raabe EH. Abstract 494: MYC, dominant negative p53 and AKT transform human neural stem cells into primitive neuro-ectodermal tumors sensitive to glutaminase inhibitors Cancer Research. 75: 494-494. DOI: 10.1158/1538-7445.Am2015-494  1
2015 Kaur H, Hütt-Cabezas M, Taylor I, Asnaghi L, Rodriguez F, Orr BA, Eberhart CG, Raabe EH. Abstract 4222: Targeting HMGA2 suppresses GBM stemness, invasion and tumorigenicity Cancer Research. 75: 4222-4222. DOI: 10.1158/1538-7445.Am2015-4222  1
2015 Rubens J, Weingart M, Price A, Hutt-Cabezas M, Taylor I, Allen S, Orr B, Eberhart C, Raabe E. Abstract 3272: Targeting LIN28 and the RAS/MAP kinase pathway in atypical teratoid rhabdoid tumors Cancer Research. 75: 3272-3272. DOI: 10.1158/1538-7445.Am2015-3272  1
2015 Sagal J, Eberhart CG, Ying M. Abstract 2892: A MYC-driven medulloblastoma model derived from human induced pluripotent stem cells Cancer Research. 75: 2892-2892. DOI: 10.1158/1538-7445.Am2015-2892  1
2015 Moster ML, Leon M, Hutchinson AK, Lenhart PD, Lambert SR. The cost-effectiveness of different strategies to evaluate optic disk drusen in children Journal of Neuro-Ophthalmology. 35: 223-224. DOI: 10.1097/Wno.0000000000000254  0.01
2015 Kahlert UD, Suwala AK, Koch K, Natsumeda M, Orr BA, Hayashi M, Maciaczyk J, Eberhart CG. Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells Journal of Neuropathology and Experimental Neurology. 74: 889-900. DOI: 10.1097/NEN.0000000000000227  1
2015 Miyahara H, Natsumeda M, Taylor I, Rubens J, Kaur H, Eberhart C, Raabe E. PTPS-22DUAL mTOR KINASE INHIBITOR (MLN0128) MARKEDLY INDUCES GROWTH SUPPRESSION AND APOPTOSIS IN DIFFUSE INTRINSIC PONTINE GLIOMA CELL LINES Neuro-Oncology. 17: v184.1-v184. DOI: 10.1093/neuonc/nov228.22  0.01
2015 Natsumeda M, Miyahara H, Kaur H, Eberhart C. MTR-10PHARMACOLOGICAL NOTCH BLOCKADE IN GLIOMAS INDUCES AUTOPHAGY AND COMBINATION TREATMENT WITH AN AUTOPHAGY INHIBITOR INCREASES TUMOR CELL DEATH Neuro-Oncology. 17: v126.2-v126. DOI: 10.1093/Neuonc/Nov219.10  0.01
2015 Yuan M, An P, Lim KS, Taylor I, Rodriguez F, Raabe E, Eberhart C. MTR-03ATRX REDUCTION PROMOTES ALKYLATING AGENT RESISTANCE AND XENOGRAFT GROWTH IN A SUBSET OF GLIOMAS Neuro-Oncology. 17: v124.3-v124. DOI: 10.1093/Neuonc/Nov219.03  0.01
2015 Karajannis M, Kannan K, Aminova O, Dolgalev I, Heguy A, Faustin A, Zagzag D, Gardner S, Allen J, Wisoff J, Capper D, Hovestadt V, Ahsan S, Eberhart C, Pfister S, et al. GENO-20NOVEL CANDIDATE ONCOGENIC DRIVERS IN PINEOBLASTOMA Neuro-Oncology. 17: v95.4-v96. DOI: 10.1093/Neuonc/Nov215.20  0.01
2015 Mangraviti A, Raghavan T, Volpin F, Skuli N, Zhou J, Eberhart C, Rodriguez F, Sankey E, Gullotti D, Liu A, Wang Y, Schriefer D, Brem H, Olivi A, Tyler B. ATPS-89LOCAL DELIVERY OF A SMALL-MOLECULE INHIBITOR OF HYPOXIA INDUCIBLE FACTOR-1: A NEW CANDIDATE DRUG FOR BRAIN TUMOR THERAPY Neuro-Oncology. 17: v38.1-v38. DOI: 10.1093/Neuonc/Nov204.89  0.01
2015 Holdhoff M, Rodriguez F, Hicks J, Zheng Q, Forman M, Ye X, Grossman SA, Burger PC, Eberhart C, De Marzo AM, Arav-Boger R. ATPS-33EVIDENCE OF ABSENCE FOR CYTOMEGALOVIRUS IN PATIENTS WITH GLIOBLASTOMAS AND OTHER HIGH-GRADE GLIOMAS BY REAL-TIME PCR FOR DNA, IMMUNOHISTOCHEMISTRY FOR PROTEIN ANDIN-SITUHYBRIDIZATION FOR mRNA Neuro-Oncology. 17: v25.2-v25. DOI: 10.1093/Neuonc/Nov204.33  0.01
2015 Snuderl M, Kannan K, Aminova O, Dolgalev I, Heguy A, Faustin A, Zagzag D, Gardner S, Allen J, Wisoff J, Capper D, Hovestadt V, Ahsan S, Eberhart C, Pfister S, et al. MB-17 * NOVEL CANDIDATE ONCOGENIC DRIVERS IN PINEOBLASTOMA Neuro-Oncology. 17: iii23-iii23. DOI: 10.1093/Neuonc/Nov061.93  0.01
2015 Brandt WD, Schreck KC, Bar EE, Taylor I, Marchionni L, Raabe E, Eberhart CG, Rodriguez FJ. Lg-04Notch Signaling Activation In Pediatric Low-Grade Astrocytoma. Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov061.73  1
2015 Rubens J, Price A, Eberhart C, Raabe E. AT-05 * TARGETING mTOR DOWNSTREAM OF LIN28 IN ATYPICAL TERATOID RHABDOID TUMORS PROMOTES APOPTOSIS AND SUPPRESSES TUMORIGENICITY Neuro-Oncology. 17: iii2-iii2. DOI: 10.1093/Neuonc/Nov061.5  0.01
2015 Taylor I, Ahsan S, Weingart M, Eberhart C, Raabe E. HG-12 * LIN28 AND MYC EXPRESSING PEDIATRIC GLIOBLASTOMAS ARE SENSITIVE TO INHIBITORS OF GLUTAMINE METABOLISM Neuro-Oncology. 17: iii13-iii13. DOI: 10.1093/Neuonc/Nov061.49  0.01
2015 Kaur H, Hutt-Cabezas M, Taylor I, Weingart M, Rodriguez F, Eberhart C, Raabe E. HG-08 * DISRUPTING THE EPIGENETIC MODIFIER HMGA2 IN DIPG AND GBM INHIBITS TUMOR INVASION, GROWTH AND TUMORIGENICITY Neuro-Oncology. 17: iii12-iii12. DOI: 10.1093/Neuonc/Nov061.45  0.01
2015 Hanaford A, Archer T, Tamayo P, Pomeroy S, Eberhart C, Raabe E. MB-27 * PATHWAY ANALYSIS OF A HUMAN NEURAL STEM CELL MODEL OF AGGRESSIVE MEDULLOBLASTOMA REVEALS CKD INBHIBITION AS A POTENTIAL THERAPEUTIC MODALITY Neuro-Oncology. 17: iii25-iii26. DOI: 10.1093/Neuonc/Nov061.103  0.01
2015 Jiang S, Blakeley J, Eberhart C, Lim M, Quinones-Hinojosa A, Zhang Y, Heo HY, Zhou J. Amide-proton-transfer MRI signal as biomarker of glioma as assessed by image-guided needle biopsy Journal of the Neurological Sciences. 357. DOI: 10.1016/J.Jns.2015.08.239  1
2015 Mastorakos P, Zhang C, Berry S, Oh Y, Lee S, Eberhart CG, Woodworth GF, Suk JS, Hanes J. DNA Nanoparticles: Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain (Adv. Healthcare Mater. 7/2015) Advanced Healthcare Materials. 4: 942-942. DOI: 10.1002/Adhm.201570040  0.01
2014 Zhukova N, Ramaswamy V, Remke M, Martin DC, Castelo-Branco P, Zhang CH, Fraser M, Tse K, Poon R, Shih DJ, Baskin B, Ray PN, Bouffet E, Dirks P, von Bueren AO, ... ... Eberhart CG, et al. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma. Acta Neuropathologica Communications. 2: 174. PMID 25539912 DOI: 10.1186/S40478-014-0174-Y  1
2014 Kahlert UD, Suwala AK, Raabe EH, Siebzehnrubl FA, Suarez MJ, Orr BA, Bar EE, Maciaczyk J, Eberhart CG. ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres. Brain Pathology (Zurich, Switzerland). PMID 25521330 DOI: 10.1111/Bpa.12240  1
2014 Asnaghi L, Alkatan H, Mahale A, Othman M, Alwadani S, Al-Hussain H, Jastaneiah S, Yu W, Maktabi A, Edward DP, Eberhart CG. Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinoma. Investigative Ophthalmology & Visual Science. 55: 8604-13. PMID 25491297 DOI: 10.1167/Iovs.14-14920  1
2014 Rusert JM, Wu X, Eberhart CG, Taylor MD, Wechsler-Reya RJ. SnapShot: Medulloblastoma. Cancer Cell. 26: 940-940.e1. PMID 25490452 DOI: 10.1016/j.ccell.2014.11.015  1
2014 Ryu J, Horkayne-Szakaly I, Xu L, Pletnikova O, Leri F, Eberhart C, Troncoso JC, Koliatsos VE. The problem of axonal injury in the brains of veterans with histories of blast exposure. Acta Neuropathologica Communications. 2: 153. PMID 25422066 DOI: 10.1186/S40478-014-0153-3  1
2014 Margolin EA, Gopwani J, Eberhart CG, Blitz AM. Mass confusion in a 30-year-old man. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 34: 408-11. PMID 25405663 DOI: 10.1097/Wno.0000000000000194  0.01
2014 Lopez-Bertoni H, Lal B, Li A, Caplan M, Guerrero-Cázares H, Eberhart CG, Quiñones-Hinojosa A, Glas M, Scheffler B, Laterra J, Li Y. DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2. Oncogene. PMID 25328136 DOI: 10.1038/Onc.2014.334  1
2014 Matthaei M, Zhu AY, Kallay L, Eberhart CG, Cursiefen C, Jun AS. Transcript profile of cellular senescence-related genes in Fuchs endothelial corneal dystrophy. Experimental Eye Research. 129: 13-7. PMID 25311168 DOI: 10.1016/J.Exer.2014.10.011  1
2014 Martin AM, Raabe E, Eberhart C, Cohen KJ. Management of pediatric and adult patients with medulloblastoma. Current Treatment Options in Oncology. 15: 581-94. PMID 25194927 DOI: 10.1007/S11864-014-0306-4  1
2014 Asnaghi L, Lin MH, Lim KS, Lim KJ, Tripathy A, Wendeborn M, Merbs SL, Handa JT, Sodhi A, Bar EE, Eberhart CG. Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation. Plos One. 9: e105372. PMID 25166211 DOI: 10.1371/Journal.Pone.0105372  1
2014 Rajaii F, Asnaghi L, Enke R, Merbs SL, Handa JT, Eberhart CG. The demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanoma. Investigative Ophthalmology & Visual Science. 55: 6178-86. PMID 25146981 DOI: 10.1167/Iovs.14-13933  1
2014 Son HS, Villarreal G, Meng H, Eberhart CG, Jun AS. On the origin of 'guttae'. The British Journal of Ophthalmology. 98: 1308-10. PMID 25012533 DOI: 10.1136/Bjophthalmol-2014-305069  1
2014 Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, et al. International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathology (Zurich, Switzerland). 24: 429-35. PMID 24990071 DOI: 10.1111/Bpa.12171  1
2014 Ahsan S, Raabe EH, Haffner MC, Vaghasia A, Warren KE, Quezado M, Ballester LY, Nazarian J, Eberhart CG, Rodriguez FJ. Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma. Acta Neuropathologica Communications. 2: 59. PMID 24894482 DOI: 10.1186/2051-5960-2-59  1
2014 Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M, Kim SK, Ra YS, Nakamura H, Fangusaro J, Hwang E, Kiehna E, Toledano H, Wang Y, Shi Q, ... ... Eberhart CG, et al. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathologica. 128: 291-303. PMID 24839957 DOI: 10.1007/S00401-014-1291-1  1
2014 AlWadani S, Robinson S, Myers R, Akpek EK, Eberhart CG. No increase in IgG4-positive plasma cells in limbal Rosai-Dorfman disease. Cornea. 33: 844-7. PMID 24831194 DOI: 10.1097/Ico.0000000000000141  1
2014 Yuan M, Eberhart CG, Kai M. RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation. Oncotarget. 5: 2820-6. PMID 24811242 DOI: 10.18632/Oncotarget.1924  1
2014 Karajannis MA, Legault G, Fisher MJ, Milla SS, Cohen KJ, Wisoff JH, Harter DH, Goldberg JD, Hochman T, Merkelson A, Bloom MC, Sievert AJ, Resnick AC, Dhall G, Jones DT, ... ... Eberhart CG, et al. Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro-Oncology. 16: 1408-16. PMID 24803676 DOI: 10.1093/Neuonc/Nou059  1
2014 Ardeljan D, Wang Y, Park S, Shen D, Chu XK, Yu CR, Abu-Asab M, Tuo J, Eberhart CG, Olsen TW, Mullins RF, White G, Wadsworth S, Scaria A, Chan CC. Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration. Plos One. 9: e95900. PMID 24780906 DOI: 10.1371/Journal.Pone.0095900  1
2014 Carvalho FL, Simons BW, Eberhart CG, Berman DM. Notch signaling in prostate cancer: a moving target. The Prostate. 74: 933-45. PMID 24737393 DOI: 10.1002/Pros.22811  0.01
2014 Hessen M, Eberhart C, Butler N, Akpek EK. Sarcoidosis presenting as scleral nodule. Ocular Immunology and Inflammation. 22: 311-3. PMID 24724703 DOI: 10.3109/09273948.2013.805786  1
2014 Tilghman J, Wu H, Sang Y, Shi X, Guerrero-Cazares H, Quinones-Hinojosa A, Eberhart CG, Laterra J, Ying M. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells. Cancer Research. 74: 3168-79. PMID 24710409 DOI: 10.1158/0008-5472.Can-13-2103  1
2014 Ding D, Lim KS, Eberhart CG. Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres. Acta Neuropathologica Communications. 2: 31. PMID 24685274 DOI: 10.1186/2051-5960-2-31  1
2014 Rodić N, Sharma R, Sharma R, Zampella J, Dai L, Taylor MS, Hruban RH, Iacobuzio-Donahue CA, Maitra A, Torbenson MS, Goggins M, Shih IeM, Duffield AS, Montgomery EA, Gabrielson E, ... ... Eberhart CG, et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. The American Journal of Pathology. 184: 1280-6. PMID 24607009 DOI: 10.1016/J.Ajpath.2014.01.007  1
2014 Zhu AY, Eberhart CG, Jun AS. Fuchs endothelial corneal dystrophy: a neurodegenerative disorder? Jama Ophthalmology. 132: 377-8. PMID 24504267 DOI: 10.1001/Jamaophthalmol.2013.7993  1
2014 Shih DJ, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM, Garzia L, Peacock J, Mack SC, Wu X, Rolider A, ... ... Eberhart CG, et al. Cytogenetic prognostication within medulloblastoma subgroups. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 886-96. PMID 24493713 DOI: 10.1200/Jco.2013.50.9539  1
2014 Matthaei M, Hu J, Kallay L, Eberhart CG, Cursiefen C, Qian J, Lackner EM, Jun AS. Endothelial cell microRNA expression in human late-onset Fuchs' dystrophy. Investigative Ophthalmology & Visual Science. 55: 216-25. PMID 24334445 DOI: 10.1167/Iovs.13-12689  1
2014 Rajan Kd A, Burris C, Iliff N, Grant M, Eshleman JR, Eberhart CG. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma. American Journal of Ophthalmology. 157: 640-7.e1-2. PMID 24321472 DOI: 10.1016/J.Ajo.2013.12.002  1
2014 Lackner EM, Matthaei M, Meng H, Ardjomand N, Eberhart CG, Jun AS. Design and analysis of keratoconus tissue microarrays. Cornea. 33: 49-55. PMID 24270675 DOI: 10.1097/Ico.0000000000000012  1
2014 Xu Z, Wei Y, Gong J, Cho H, Park JK, Sung ER, Huang H, Wu L, Eberhart C, Handa JT, Du Y, Kern TS, Thimmulappa R, Barber AJ, Biswal S, et al. NRF2 plays a protective role in diabetic retinopathy in mice. Diabetologia. 57: 204-13. PMID 24186494 DOI: 10.1007/S00125-013-3093-8  1
2014 Ho CY, Troncoso JC, Knox D, Stark W, Eberhart CG. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients. Brain Pathology (Zurich, Switzerland). 24: 25-32. PMID 23714377 DOI: 10.1111/Bpa.12070  1
2014 Ahsan S, Raabe E, Haffner MC, Nazarian J, Warren K, Ballester L, Quezado M, Eberhart C, Rodriguez FJ. Abstract 384: Epigenetic derangements in histone and cytosine methylation are unique to diffuse intrinsic pontine glioma (DIPG) Cancer Research. 74: 384-384. DOI: 10.1158/1538-7445.Am2014-384  1
2014 Taylor IC, Hutt-Cabezas M, Weingart M, Warren K, Chang H, Nazarian J, Eberhart CG, Raabe EH. Abstract 3099: Dual targeting of mTOR and Notch disrupts growth and promotes apoptosis in diffuse intrinsic pontine glioma Cancer Research. 74: 3099-3099. DOI: 10.1158/1538-7445.Am2014-3099  1
2014 Hanaford AR, Eberhart CG, Raabe EH. Abstract 3090: Targeting glutamine metabolism as a therapeutic strategy in MYC-driven medulloblastoma Cancer Research. 74: 3090-3090. DOI: 10.1158/1538-7445.Am2014-3090  1
2014 Kaur H, Hütt M, Mao X, Orr BA, Eberhart CG, Raabe EH. Abstract 3031: HMGA2 promotes invasion and stemness in glioblastoma Cancer Research. 74: 3031-3031. DOI: 10.1158/1538-7445.Am2014-3031  1
2014 Kahlert UD, Raabe EE, Siebzehnrubl FA, Bar EE, Maciaczyk J, Eberhart CG. Abstract 1038: ZEB1 plays a pivotal role in hypoxia-mediated increase ofin vitroinvasion of glioblastoma-derived cell cultures and represents a novel neural stem cell marker in early development Cancer Research. 74: 1038-1038. DOI: 10.1158/1538-7445.Am2014-1038  1
2014 Wang J, Eberhart C, Ellison D, Vandenberg S, Wechsler-Reya R. PM-22 * GENETICALLY ENGINEERED MOUSE MODELS OF CHOROID PLEXUS TUMORS Neuro-Oncology. 16: v173-v173. DOI: 10.1093/Neuonc/Nou268.22  0.01
2014 Natsumeda M, Zhang H, Kaur H, Asnaghi L, Eberhart CG. DS-02 * INDUCTION OF AUTOPHAGY MARKERS IN GLIOMAS FOLLOWING PHARMACOLOGICAL NOTCH BLOCKADE Neuro-Oncology. 16: v65-v65. DOI: 10.1093/Neuonc/Nou244.2  0.01
2014 Laterra J, Lopez-Bertoni H, Lal B, Li A, Caplan M, Guerrero-Cazares H, Eberhart CG, Quinones-Hinojosa A, Li Y. EPIGENETIC REGULATION OF GBM CELL STEMNESS AND TUMOR PROPAGATING CAPACITY BY OCT4 AND SOX2 Neuro-Oncology. 16: iii15-iii15. DOI: 10.1093/Neuonc/Nou206.54  0.01
2014 Eberhart C, Raabe E, Hanaford A, Pomeroy S. MODELLING HIGH MYC MEDULLOBLASTOMA AND OTHER BRAIN TUMORS USING HUMAN NEURAL STEM CELLS Neuro-Oncology. 16: iii4-iii4. DOI: 10.1093/Neuonc/Nou206.12  0.01
2014 Classen CF, William D, Linnebacher M, Farhod A, Kedr W, Elsabe B, Fadel S, Van Gool S, De Vleeschouwer S, Koks C, Garg A, Ehrhardt M, Riva M, De Vleeschouwer S, Agostinis P, ... ... Eberhart C, ... ... Eberhart C, et al. HIGH GRADE GLIOMAS AND DIPG Neuro-Oncology. 16: i40-i59. DOI: 10.1093/Neuonc/Nou071  1
2013 Baia GS, Caballero OL, Ho JS, Zhao Q, Cohen T, Binder ZA, Salmasi V, Gallia GL, Quinones-Hinojosa A, Olivi A, Brem H, Burger P, Strausberg RL, Simpson AJ, Eberhart CG, et al. NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches. Cancer Immunology Research. 1: 296-302. PMID 24777967 DOI: 10.1158/2326-6066.Cir-13-0029  1
2013 Rajaii F, Ghafourian A, Eberhart CG. Intratarsal keratinous cyst - an emerging entity. Case Reports in Ophthalmology. 4: 160-4. PMID 24403898 DOI: 10.1159/000355582  1
2013 Hütt-Cabezas M, Karajannis MA, Zagzag D, Shah S, Horkayne-Szakaly I, Rushing EJ, Cameron JD, Jain D, Eberhart CG, Raabe EH, Rodriguez FJ. Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target. Neuro-Oncology. 15: 1604-14. PMID 24203892 DOI: 10.1093/Neuonc/Not132  1
2013 Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, ... ... Eberhart CG, et al. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathologica. 126: 917-29. PMID 24174164 DOI: 10.1007/S00401-013-1198-2  1
2013 Binder ZA, Siu IM, Eberhart CG, Ap Rhys C, Bai RY, Staedtke V, Zhang H, Smoll NR, Piantadosi S, Piccirillo SG, Dimeco F, Weingart JD, Vescovi A, Olivi A, Riggins GJ, et al. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome. Plos One. 8: e75945. PMID 24146797 DOI: 10.1371/Journal.Pone.0075945  1
2013 Wong RK, Greene DP, Shield DR, Eberhart CG, Huang JJ, Shayegani A. 5-Fluorouracil for epithelial downgrowth after Descemet stripping automated endothelial keratoplasty. Cornea. 32: 1610-2. PMID 24113368 DOI: 10.1097/Ico.0B013E3182A9Fc85  1
2013 Borodovsky A, Salmasi V, Turcan S, Fabius AW, Baia GS, Eberhart CG, Weingart JD, Gallia GL, Baylin SB, Chan TA, Riggins GJ. 5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft. Oncotarget. 4: 1737-47. PMID 24077805 DOI: 10.18632/Oncotarget.1408  1
2013 Ballester LY, Wang Z, Shandilya S, Miettinen M, Burger PC, Eberhart CG, Rodriguez FJ, Raabe E, Nazarian J, Warren K, Quezado MM. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas. The American Journal of Surgical Pathology. 37: 1357-64. PMID 24076776 DOI: 10.1097/Pas.0B013E318294E817  1
2013 Heaphy CM, Schreck KC, Raabe E, Mao XG, An P, Chu Q, Poh W, Jiao Y, Rodriguez FJ, Odia Y, Meeker AK, Eberhart CG. A glioblastoma neurosphere line with alternative lengthening of telomeres. Acta Neuropathologica. 126: 607-8. PMID 24022427 DOI: 10.1007/S00401-013-1174-X  1
2013 Xin X, Rodrigues M, Umapathi M, Kashiwabuchi F, Ma T, Babapoor-Farrokhran S, Wang S, Hu J, Bhutto I, Welsbie DS, Duh EJ, Handa JT, Eberhart CG, Lutty G, Semenza GL, et al. Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. Proceedings of the National Academy of Sciences of the United States of America. 110: E3425-34. PMID 23959876 DOI: 10.1073/Pnas.1217091110  1
2013 Odia Y, Orr BA, Bell WR, Eberhart CG, Rodriguez FJ. cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome. Journal of Neuro-Oncology. 115: 249-59. PMID 23934175 DOI: 10.1007/S11060-013-1221-4  1
2013 Hsu AW, Sodhi A, Eberhart C, Montaner S, Goldberg MF. Regression of choroidal neovascularization in response to systemic chemotherapy for cancer. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. 48: e80-2. PMID 23931490 DOI: 10.1016/J.Jcjo.2013.02.004  1
2013 Rodrigues M, Iliff NT, Eberhart CG, Montaner S, Sodhi A. Scleral penetration of an unusually aggressive case of a retinal hemangioblastoma. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. 48: e67-71. PMID 23931485 DOI: 10.1016/J.Jcjo.2013.01.014  1
2013 Spina R, Filocamo G, Iaccino E, Scicchitano S, Lupia M, Chiarella E, Mega T, Bernaudo F, Pelaggi D, Mesuraca M, Pazzaglia S, Semenkow S, Bar EE, Kool M, Pfister S, ... ... Eberhart CG, et al. Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells. Oncotarget. 4: 1280-92. PMID 23907569 DOI: 10.18632/Oncotarget.1176  1
2013 Mao XG, Hütt-Cabezas M, Orr BA, Weingart M, Taylor I, Rajan AK, Odia Y, Kahlert U, Maciaczyk J, Nikkhah G, Eberhart CG, Raabe EH. LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program. Oncotarget. 4: 1050-64. PMID 23846349 DOI: 10.18632/Oncotarget.1131  1
2013 Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJ, Martin DC, Castelo-Branco P, Baskin B, Ray PN, Bouffet E, von Bueren AO, Jones DT, Northcott PA, Kool M, Sturm D, ... ... Eberhart CG, et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2927-35. PMID 23835706 DOI: 10.1200/Jco.2012.48.5052  1
2013 Jones DT, Hutter B, Jäger N, Korshunov A, Kool M, Warnatz HJ, Zichner T, Lambert SR, Ryzhova M, Quang DA, Fontebasso AM, Stütz AM, Hutter S, Zuckermann M, Sturm D, ... ... Eberhart CG, et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nature Genetics. 45: 927-32. PMID 23817572 DOI: 10.1038/Ng.2682  1
2013 Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE, McKenna A, Lawrence MS, Bergthold G, Brastianos PK, Tabak B, Ducar MD, Van Hummelen P, MacConaill LE, Pouissant-Young T, ... ... Eberhart CG, et al. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proceedings of the National Academy of Sciences of the United States of America. 110: 8188-93. PMID 23633565 DOI: 10.1073/Pnas.1300252110  1
2013 Chu Q, Orr BA, Semenkow S, Bar EE, Eberhart CG. Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockade. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3224-33. PMID 23630166 DOI: 10.1158/1078-0432.Ccr-12-2119  1
2013 Matthaei M, Hu J, Meng H, Lackner EM, Eberhart CG, Qian J, Hao H, Jun AS. Endothelial cell whole genome expression analysis in a mouse model of early-onset Fuchs' endothelial corneal dystrophy. Investigative Ophthalmology & Visual Science. 54: 1931-40. PMID 23449721 DOI: 10.1167/Iovs.12-10898  1
2013 Zhou J, Zhu H, Lim M, Blair L, Quinones-Hinojosa A, Messina SA, Eberhart CG, Pomper MG, Laterra J, Barker PB, van Zijl PC, Blakeley JO. Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. Journal of Magnetic Resonance Imaging : Jmri. 38: 1119-28. PMID 23440878 DOI: 10.1002/Jmri.24067  1
2013 Meng H, Matthaei M, Ramanan N, Grebe R, Chakravarti S, Speck CL, Kimos M, Vij N, Eberhart CG, Jun AS. L450W and Q455K Col8a2 knock-in mouse models of Fuchs endothelial corneal dystrophy show distinct phenotypes and evidence for altered autophagy. Investigative Ophthalmology & Visual Science. 54: 1887-97. PMID 23422828 DOI: 10.1167/Iovs.12-11021  1
2013 Zheng G, Martignoni G, Antonescu C, Montgomery E, Eberhart C, Netto G, Taube J, Westra W, Epstein JI, Lotan T, Maitra A, Gabrielson E, Torbenson M, Iacobuzio-Donahue C, Demarzo A, et al. A broad survey of cathepsin k immunoreactivity in human neoplasms American Journal of Clinical Pathology. 139: 151-159. PMID 23355199 DOI: 10.1309/Ajcpdtrto2Z4Uexd  1
2013 Vellimana AK, Recinos VR, Hwang L, Fowers KD, Li KW, Zhang Y, Okonma S, Eberhart CG, Brem H, Tyler BM. Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model. Journal of Neuro-Oncology. 111: 229-36. PMID 23224713 DOI: 10.1007/S11060-012-1014-1  1
2013 Asnaghi L, Handa JT, Merbs SL, Harbour JW, Eberhart CG. A role for Jag2 in promoting uveal melanoma dissemination and growth. Investigative Ophthalmology & Visual Science. 54: 295-306. PMID 23211831 DOI: 10.1167/Iovs.12-10209  1
2013 Dubuc AM, Remke M, Korshunov A, Northcott PA, Zhan SH, Mendez-Lago M, Kool M, Jones DT, Unterberger A, Morrissy AS, Shih D, Peacock J, Ramaswamy V, Rolider A, Wang X, ... ... Eberhart CG, et al. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Acta Neuropathologica. 125: 373-84. PMID 23184418 DOI: 10.1007/S00401-012-1070-9  1
2013 Ho CY, Bar E, Giannini C, Marchionni L, Karajannis MA, Zagzag D, Gutmann DH, Eberhart CG, Rodriguez FJ. MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2. Neuro-Oncology. 15: 69-82. PMID 23161775 DOI: 10.1093/Neuonc/Nos269  1
2013 Matthaei M, Lackner EM, Meng H, Hicks JL, Meeker AK, Eberhart CG, Jun AS. Tissue microarray analysis of cyclin-dependent kinase inhibitors p21 and p16 in Fuchs dystrophy. Cornea. 32: 473-8. PMID 23132454 DOI: 10.1097/Ico.0B013E31826F324E  1
2013 Rodriguez FJ, Lim KS, Bowers D, Eberhart CG. Pathological and molecular advances in pediatric low-grade astrocytoma. Annual Review of Pathology. 8: 361-79. PMID 23121055 DOI: 10.1146/Annurev-Pathol-020712-164009  1
2013 Aref D, Moffatt CJ, Agnihotri S, Ramaswamy V, Dubuc AM, Northcott PA, Taylor MD, Perry A, Olson JM, Eberhart CG, Croul SE. Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development. Brain Pathology (Zurich, Switzerland). 23: 178-91. PMID 22966790 DOI: 10.1111/J.1750-3639.2012.00631.X  1
2013 Nguyen DN, Heaphy CM, de Wilde RF, Orr BA, Odia Y, Eberhart CG, Meeker AK, Rodriguez FJ. Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathology (Zurich, Switzerland). 23: 237-43. PMID 22928601 DOI: 10.1111/J.1750-3639.2012.00630.X  1
2013 Das CM, Taylor P, Gireud M, Singh A, Lee D, Fuller G, Ji L, Fangusaro J, Rajaram V, Goldman S, Eberhart C, Gopalakrishnan V. The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation. Oncogene. 32: 1691-701. PMID 22665064 DOI: 10.1038/Onc.2012.182  1
2013 Raabe E, G. Eberhart C. Therapeutic Targeting of Developmental Signaling Pathways in Medulloblastoma: Hedgehog, Notch, Wnt and Myc Current Signal Transduction Therapy. 8: 55-66. DOI: 10.2174/1574362411308010008  0.01
2013 Ventura B, Yao M, Jiang Y, Wahl K, Rodriguez F, Eberhart CG, Zong H. Abstract PR09: Fine temporal and spatial dissection of medulloblastoma progression with MADM, a mouse genetic mosaic model Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Pr09  1
2013 Ahsan SF, Hanaford A, Weingart M, Taylor I, Eberhart C, Raabe E. Abstract 5051: MYC-driven models of primitive neuroectodermal tumor are sensitive to inhibitors of glutamine metabolism. Cancer Research. 73: 5051-5051. DOI: 10.1158/1538-7445.Am2013-5051  1
2013 Hutt M, Goldstein W, Nazarian J, Price A, Lim KJ, Warren K, Chang H, Eberhart C, Raabe E. Abstract 5049: Targeting the Notch and mTOR pathways in diffuse intrinsic pontine glioma. Cancer Research. 73: 5049-5049. DOI: 10.1158/1538-7445.Am2013-5049  1
2013 Shah S, Hutt M, Karajannis MA, Raabe E, Eberhart CG, Rodriguez FJ. Abstract 5048: mTORC1/mTORC2 signaling in pediatric low grade glioma and pilocytic astrocytoma. Cancer Research. 73: 5048-5048. DOI: 10.1158/1538-7445.Am2013-5048  1
2013 Spina R, Filocamo G, Iaccino E, Scicchitano S, Lupia M, Chiarella E, Mega T, Pelaggi D, Mesuraca M, Bar EE, Bond HM, Eberhart CG, Steinkuhler C, Morrone G. Abstract 5045: Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells. Cancer Research. 73: 5045-5045. DOI: 10.1158/1538-7445.Am2013-5045  1
2013 Taylor I, Kahlert U, Maciaczyk J, Nikkhah G, Eberhart C, Raabe EH. Abstract 5044: MYC drives formation of primative neuro-ectodermal tumors in human neural stem cells derived from multiple brain regions. Cancer Research. 73: 5044-5044. DOI: 10.1158/1538-7445.Am2013-5044  1
2013 Asnaghi L, Lin MH, Lim KS, Lim KJ, Bar EE, Eberhart CG. Abstract 3776: Hypoxia-inducible factor 1α (HIF1α) has a prometastatic effect in uveal melanoma . Cancer Research. 73: 3776-3776. DOI: 10.1158/1538-7445.Am2013-3776  1
2013 Kaur H, Hutt M, Mao X, Eberhart CG, Raabe EH. Abstract 3742: Targeting the stem cell factor HMGA2 to improve outcomes in glioblastoma. Cancer Research. 73: 3742-3742. DOI: 10.1158/1538-7445.Am2013-3742  1
2013 Lim KS, Lim KJ, Orr BA, Price AC, Eberhart CG, Bar EE. Abstract 2930: Silencing MCT4 inhibits GBM growth, HIF response, and CD133-positive fraction in a lactate-independent fashion. Cancer Research. 73: 2930-2930. DOI: 10.1158/1538-7445.Am2013-2930  1
2013 Ding D, Kahlert U, Maciaczyk J, Nikkhah G, Eberhart C, Raabe E. Abstract 2607: BMI1 and dominant negative p53 cooperate to suppress AKT-mediated oncogene-induced senescence and promote transformation in human neural stem cells. Cancer Research. 73: 2607-2607. DOI: 10.1158/1538-7445.Am2013-2607  1
2013 Hanaford AR, Eberhart CG, Raabe EH. Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism. Cancer Research. 73: 1872-1872. DOI: 10.1158/1538-7445.Am2013-1872  1
2013 Caretti V, Noll A, Woo P, Monje M, Cockle J, Bruning-Richardson A, Picton S, Levesley J, Ilett E, Short S, Melcher A, Lawler S, Garzia L, Dubuc A, Pitcher G, et al. PEDIATRICS LABORATORY RESEARCH Neuro-Oncology. 15: iii173-iii177. DOI: 10.1093/Neuonc/Not186  0.01
2013 Aaberg-Jessen C, Fogh L, Halle B, Jensen V, Brunner N, Kristensen BW, Abe T, Momii Y, Watanabe J, Morisaki I, Natsume A, Wakabayashi T, Fujiki M, Aldaz B, Fabius AWM, ... ... Eberhart C, et al. EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 15: iii37-iii61. DOI: 10.1093/Neuonc/Not176  0.01
2013 Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, ... ... Eberhart C, et al. CELL BIOLOGY AND SIGNALING Neuro-Oncology. 15: iii12-iii31. DOI: 10.1093/Neuonc/Not174  0.01
2012 Kahlert UD, Bender NO, Maciaczyk D, Bogiel T, Bar EE, Eberhart CG, Nikkhah G, Maciaczyk J. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component. Folia Neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences. 50: 357-68. PMID 23319191 DOI: 10.5114/Fn.2012.32365  1
2012 Raabe EH, Eberhart CG. Methylome alterations "mark" new therapeutic opportunities in glioblastoma. Cancer Cell. 22: 417-8. PMID 23079650 DOI: 10.1016/J.Ccr.2012.10.001  1
2012 Grossman R, Tyler B, Brem H, Eberhart CG, Wang S, Fu DX, Wen Z, Zhou J. Growth properties of SF188/V+ human glioma in rats in vivo observed by magnetic resonance imaging. Journal of Neuro-Oncology. 110: 315-23. PMID 23011120 DOI: 10.1007/S11060-012-0974-5  1
2012 Bai RY, Staedtke V, Lidov HG, Eberhart CG, Riggins GJ. OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells. Cancer Research. 72: 5988-6001. PMID 22986744 DOI: 10.1158/0008-5472.Can-12-0614  1
2012 Matthaei M, Meng H, Meeker AK, Eberhart CG, Jun AS. Endothelial Cdkn1a (p21) overexpression and accelerated senescence in a mouse model of Fuchs endothelial corneal dystrophy. Investigative Ophthalmology & Visual Science. 53: 6718-27. PMID 22956607 DOI: 10.1167/Iovs.12-9669  1
2012 Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D, Mosier S, Lin MT, Eberhart CG, Burger PC. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathologica. 124: 627-41. PMID 22941225 DOI: 10.1007/S00401-012-1037-X  1
2012 Nance EA, Woodworth GF, Sailor KA, Shih TY, Xu Q, Swaminathan G, Xiang D, Eberhart C, Hanes J. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Science Translational Medicine. 4: 149ra119. PMID 22932224 DOI: 10.1126/Scitranslmed.3003594  1
2012 Rodriguez FJ, Ligon AH, Horkayne-Szakaly I, Rushing EJ, Ligon KL, Vena N, Garcia DI, Cameron JD, Eberhart CG. BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper. Journal of Neuropathology and Experimental Neurology. 71: 789-94. PMID 22892521 DOI: 10.1097/Nen.0B013E3182656Ef8  1
2012 Northcott PA, Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE, Beroukhim R, Ellison DW, Marshall CR, Lionel AC, Mack S, ... ... Eberhart CG, et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature. 488: 49-56. PMID 22832581 DOI: 10.1038/Nature11327  1
2012 Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. Plos One. 7: e41036. PMID 22829908 DOI: 10.1371/Journal.Pone.0041036  1
2012 Lim KJ, Rajan K, Eberhart CG. Effects of Zeng Sheng Ping/ACAPHA on malignant brain tumor growth and Notch signaling. Anticancer Research. 32: 2689-96. PMID 22753727  1
2012 Craig JM, Vena N, Ramkissoon S, Idbaih A, Fouse SD, Ozek M, Sav A, Hill DA, Margraf LR, Eberhart CG, Kieran MW, Norden AD, Wen PY, Loda M, Santagata S, et al. DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues. Plos One. 7: e38881. PMID 22719973 DOI: 10.1371/Journal.Pone.0038881  1
2012 Picard D, Miller S, Hawkins CE, Bouffet E, Rogers HA, Chan TS, Kim SK, Ra YS, Fangusaro J, Korshunov A, Toledano H, Nakamura H, Hayden JT, Chan J, Lafay-Cousin L, ... ... Eberhart C, et al. Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. The Lancet. Oncology. 13: 838-48. PMID 22691720 DOI: 10.1016/S1470-2045(12)70257-7  1
2012 Li M, Lockwood W, Zielenska M, Northcott P, Ra YS, Bouffet E, Yoshimoto M, Rutka JT, Yan H, Taylor MD, Eberhart C, Hawkins CE, Lam W, Squire JA, Huang A. Multiple CDK/CYCLIND genes are amplified in medulloblastoma and supratentorial primitive neuroectodermal brain tumor. Cancer Genetics. 205: 220-31. PMID 22682621 DOI: 10.1016/J.Cancergen.2012.03.002  1
2012 Kahlert UD, Maciaczyk D, Doostkam S, Orr BA, Simons B, Bogiel T, Reithmeier T, Prinz M, Schubert J, Niedermann G, Brabletz T, Eberhart CG, Nikkhah G, Maciaczyk J. Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. Cancer Letters. 325: 42-53. PMID 22652173 DOI: 10.1016/J.Canlet.2012.05.024  1
2012 Dokey A, Ramulu PY, Utine CA, Tzu JH, Eberhart CG, Shan S, Gelhbach PL, Akpek EK. Chronic hypotony associated with the Boston type 1 keratoprosthesis. American Journal of Ophthalmology. 154: 266-271.e1. PMID 22633347 DOI: 10.1016/J.Ajo.2012.03.001  1
2012 Orr BA, Eberhart CG. Nature versus nurture in glioblastoma: microenvironment and genetics can both drive mesenchymal transcriptional signature. The American Journal of Pathology. 180: 1768-71. PMID 22449951 DOI: 10.1016/J.Ajpath.2012.03.001  1
2012 Dubuc AM, Morrissy AS, Kloosterhof NK, Northcott PA, Yu EP, Shih D, Peacock J, Grajkowska W, van Meter T, Eberhart CG, Pfister S, Marra MA, Weiss WA, Scherer SW, Rutka JT, et al. Subgroup-specific alternative splicing in medulloblastoma. Acta Neuropathologica. 123: 485-99. PMID 22358458 DOI: 10.1007/S00401-012-0959-7  1
2012 Wu X, Northcott PA, Dubuc A, Dupuy AJ, Shih DJ, Witt H, Croul S, Bouffet E, Fults DW, Eberhart CG, Garzia L, Van Meter T, Zagzag D, Jabado N, Schwartzentruber J, et al. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature. 482: 529-33. PMID 22343890 DOI: 10.1038/Nature10825  1
2012 Eberhart CG. Three down and one to go: modeling medulloblastoma subgroups. Cancer Cell. 21: 137-8. PMID 22340583 DOI: 10.1016/J.Ccr.2012.01.013  0.01
2012 Rodriguez FJ, Orr BA, Ligon KL, Eberhart CG. Neoplastic cells are a rare component in human glioblastoma microvasculature. Oncotarget. 3: 98-106. PMID 22298889 DOI: 10.18632/Oncotarget.427  1
2012 Chen LY, Kesen MR, Ghafourian A, Nguyen QD, Eberhart CG, Do DV. Isolated endogenous Nocardia endophthalmitis after immunosuppression. Journal of Ophthalmic Inflammation and Infection. 2: 141-3. PMID 22278699 DOI: 10.1007/S12348-011-0057-3  1
2012 Asnaghi L, Ebrahimi KB, Schreck KC, Bar EE, Coonfield ML, Bell WR, Handa J, Merbs SL, Harbour JW, Eberhart CG. Notch signaling promotes growth and invasion in uveal melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 654-65. PMID 22228632 DOI: 10.1158/1078-0432.Ccr-11-1406  1
2012 Lin A, Rodriguez FJ, Karajannis MA, Williams SC, Legault G, Zagzag D, Burger PC, Allen JC, Eberhart CG, Bar EE. BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. Journal of Neuropathology and Experimental Neurology. 71: 66-72. PMID 22157620 DOI: 10.1097/Nen.0B013E31823F2Cb0  1
2012 Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathologica. 123: 465-72. PMID 22134537 DOI: 10.1007/S00401-011-0922-Z  1
2012 Northcott PA, Shih DJ, Remke M, Cho YJ, Kool M, Hawkins C, Eberhart CG, Dubuc A, Guettouche T, Cardentey Y, Bouffet E, Pomeroy SL, Marra M, Malkin D, Rutka JT, et al. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathologica. 123: 615-26. PMID 22057785 DOI: 10.1007/S00401-011-0899-7  1
2012 Lim KS, Lim KJ, Orr BA, Price AC, Eberhart CG, Bar EE. Abstract 3483: Inhibition of Monocarboxylate Transporter 4 (MCT4) targets stem-like cells in glioblastoma Cancer Research. 72: 3483-3483. DOI: 10.1158/1538-7445.Am2012-3483  1
2012 Lim KJ, Eberhart CG, Bar EE. Abstract 3335: The potential role of lateral inhibition in the maintenance of glioblastoma cancer stem cells Cancer Research. 72: 3335-3335. DOI: 10.1158/1538-7445.Am2012-3335  1
2012 Hutt M, Lim KJ, Warren K, Chang HT, Eberhart CG, Raabe EH. Abstract 2480: High-level activation of the Notch pathway in diffuse intrinsic pontine glioma Cancer Research. 72: 2480-2480. DOI: 10.1158/1538-7445.Am2012-2480  1
2012 Kozono D, Nitta M, Sampetrean O, Kimberly N, Kushwaha D, Merzon D, Ligon K, Zhu S, Zhu K, Kim TH, Kwon C, Becher O, Saya H, Chen CC, Donovan LK, ... ... Eberhart CG, et al. LAB-STEM CELLS Neuro-Oncology. 14: vi142-vi152. DOI: 10.1093/Neuonc/Nos239  0.01
2012 Carvalho D, Bjerke L, Bax D, Chen L, Kozarewa I, Baker S, Grundy R, Ashworth A, Lord C, Hargrave D, Reis RM, Jones C, Bender S, Feng W, Jones DT, ... ... Eberhart CG, ... ... Eberhart CG, et al. LAB-PEDIATRICS LABORATORY RESEARCH Neuro-Oncology. 14: vi116-vi119. DOI: 10.1093/Neuonc/Nos235  0.01
2012 Furuse M, Miyatake S, Miyata T, Yoritsune E, Kawabata S, Kuroiwa T, Karajannis MA, Fisher MJ, Milla SS, Cohen KJ, Legault G, Wisoff JH, Harter DH, Hartnett E, Merkelson A, ... ... Eberhart CG, et al. Clin-Ongoing Clinical Trials Neuro-Oncology. 14. DOI: 10.1093/Neuonc/Nos232  1
2012 Noch E, Pina-Oviedo S, Perez-Liz G, Bookland M, Del Valle L, Gordon J, Khalili K, Juratli TA, Peitzsch M, Geiger K, Schackert G, Eisenhofer G, Krex D, Chaumeil MM, Woods SM, ... ... Eberhart CG, et al. LAB-METABOLIC PATHWAYS Neuro-Oncology. 14: vi53-vi55. DOI: 10.1093/Neuonc/Nos226  0.01
2012 Kijima N, Hosen N, Kagawa N, Hashimoto N, Chiba Y, Kinoshita M, Sugiyama H, Yoshimine T, Kim YZ, Kim KH, Lee EH, Hu B, Sim H, Mohan N, Agudelo-Garcia P, ... ... Eberhart CG, et al. LAB-CELL BIOLOGY AND SIGNALING Neuro-Oncology. 14: vi7-vi20. DOI: 10.1093/Neuonc/Nos220  0.01
2012 Zaghloul M, Ahmed S, Eldebaway E, Mousa A, Amin A, Elkhateeb N, Sabry M, Ogiwara H, Morota N, Sufit A, Donson A, Birks D, Patel P, Foreman N, Handler M, ... ... Eberhart C, ... ... Eberhart C, et al. DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) Neuro-Oncology. 14: i26-i32. DOI: 10.1093/Neuonc/Nos098  0.01
2011 Blakeley JO, Ye X, Lim M, Zhu H, Blair L, Quinones-Hinojosa A, Eberhart C, Barker P, Laterra J, van Zijl PC, Zhou J. The role of amide proton transfer imaging in detecting active malignant glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2024. PMID 28023846 DOI: 10.1200/Jco.2011.29.15_Suppl.2024  1
2011 Hindman HB, McCally RL, Kim A, D'Anna SE, Eberhart CG, Jun AS. Evaluation of the effects of circular Descemet's membrane incision on the biomechanical, topographic and optical properties of rabbit corneas. Clinical & Experimental Ophthalmology. 39: 691-9. PMID 22212852 DOI: 10.1111/J.1442-9071.2011.02518.X  1
2011 Karafin M, Jallo GI, Ayars M, Eberhart CG, Rodriguez FJ. Rosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implications. Clinical Neuropathology. 30: 297-300. PMID 22011734  1
2011 Ma B, Sen T, Asnaghi L, Valapala M, Yang F, Hose S, McLeod DS, Lu Y, Eberhart C, Zigler JS, Sinha D. βA3/A1-Crystallin controls anoikis-mediated cell death in astrocytes by modulating PI3K/AKT/mTOR and ERK survival pathways through the PKD/Bit1-signaling axis. Cell Death & Disease. 2: e217. PMID 21993393 DOI: 10.1038/Cddis.2011.100  1
2011 Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, Shih IeM, Iacobuzio-Donahue CA, Maitra A, Li QK, Eberhart CG, et al. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. The American Journal of Pathology. 179: 1608-15. PMID 21888887 DOI: 10.1016/J.Ajpath.2011.06.018  1
2011 Gerber DE, Gallia GL, Tyler BM, Eberhart CG, Royer G, Grossman SA. A novel polymer gel for the delivery of local therapies to intracranial tumors: In vivo safety evaluation. Journal of Biomedical Materials Research. Part A. 99: 479-84. PMID 21887743 DOI: 10.1002/Jbm.A.33207  1
2011 Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, Bettegowda C, Rodriguez FJ, Eberhart CG, Hebbar S, Offerhaus GJ, McLendon R, Rasheed BA, He Y, Yan H, et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science (New York, N.Y.). 333: 425. PMID 21719641 DOI: 10.1126/Science.1207313  1
2011 Northcott PA, Hielscher T, Dubuc A, Mack S, Shih D, Remke M, Al-Halabi H, Albrecht S, Jabado N, Eberhart CG, Grajkowska W, Weiss WA, Clifford SC, Bouffet E, Rutka JT, et al. Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathologica. 122: 231-40. PMID 21681522 DOI: 10.1007/S00401-011-0846-7  1
2011 Orr BA, Bai H, Odia Y, Jain D, Anders RA, Eberhart CG. Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth. Journal of Neuropathology and Experimental Neurology. 70: 568-77. PMID 21666501 DOI: 10.1097/Nen.0B013E31821Ff8D8  1
2011 Raabe EH, Lim KS, Kim JM, Meeker A, Mao XG, Nikkhah G, Maciaczyk J, Kahlert U, Jain D, Bar E, Cohen KJ, Eberhart CG. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3590-9. PMID 21636552 DOI: 10.1158/1078-0432.Ccr-10-3349  1
2011 Li Y, Li A, Glas M, Lal B, Ying M, Sang Y, Xia S, Trageser D, Guerrero-Cázares H, Eberhart CG, Quiñones-Hinojosa A, Scheffler B, Laterra J. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proceedings of the National Academy of Sciences of the United States of America. 108: 9951-6. PMID 21628563 DOI: 10.1073/Pnas.1016912108  1
2011 Wei Y, Gong J, Yoshida T, Eberhart CG, Xu Z, Kombairaju P, Sporn MB, Handa JT, Duh EJ. Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury. Free Radical Biology & Medicine. 51: 216-24. PMID 21545836 DOI: 10.1016/J.Freeradbiomed.2011.04.026  1
2011 Koliatsos VE, Cernak I, Xu L, Song Y, Savonenko A, Crain BJ, Eberhart CG, Frangakis CE, Melnikova T, Kim H, Lee D. A mouse model of blast injury to brain: initial pathological, neuropathological, and behavioral characterization. Journal of Neuropathology and Experimental Neurology. 70: 399-416. PMID 21487304 DOI: 10.1097/Nen.0B013E3182189F06  1
2011 Wu-Chen WY, Weng CY, Rajan KD, Eberhart C, Miller NR. Unusual presentation of primary orbital microcystic adnexal carcinoma. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 31: 147-50. PMID 21368669 DOI: 10.1097/Wno.0B013E31820Aff28  1
2011 Zhang C, Asnaghi L, Gongora C, Patek B, Hose S, Ma B, Fard MA, Brako L, Singh K, Goldberg MF, Handa JT, Lo WK, Eberhart CG, Zigler JS, Sinha D. A developmental defect in astrocytes inhibits programmed regression of the hyaloid vasculature in the mammalian eye. European Journal of Cell Biology. 90: 440-8. PMID 21354650 DOI: 10.1016/j.ejcb.2011.01.003  1
2011 von Bueren AO, Oehler C, Shalaby T, von Hoff K, Pruschy M, Seifert B, Gerber NU, Warmuth-Metz M, Stearns D, Eberhart CG, Kortmann RD, Rutkowski S, Grotzer MA. c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. Bmc Cancer. 11: 74. PMID 21324178 DOI: 10.1186/1471-2407-11-74  1
2011 Engler C, Chakravarti S, Doyle J, Eberhart CG, Meng H, Stark WJ, Kelliher C, Jun AS. Transforming growth factor-β signaling pathway activation in Keratoconus. American Journal of Ophthalmology. 151: 752-759.e2. PMID 21310385 DOI: 10.1016/J.Ajo.2010.11.008  1
2011 Ying M, Sang Y, Li Y, Guerrero-Cazares H, Quinones-Hinojosa A, Vescovi AL, Eberhart CG, Xia S, Laterra J. Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells. Stem Cells (Dayton, Ohio). 29: 20-31. PMID 21280156 DOI: 10.1002/Stem.561  1
2011 Pierfelice TJ, Schreck KC, Dang L, Asnaghi L, Gaiano N, Eberhart CG. Notch3 activation promotes invasive glioma formation in a tissue site-specific manner. Cancer Research. 71: 1115-25. PMID 21245095 DOI: 10.1158/0008-5472.Can-10-0690  1
2011 Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biology & Therapy. 11: 464-73. PMID 21193839 DOI: 10.4161/Cbt.11.5.14410  1
2011 Eberhart CG. Molecular diagnostics in embryonal brain tumors. Brain Pathology (Zurich, Switzerland). 21: 96-104. PMID 21129063 DOI: 10.1111/J.1750-3639.2010.00455.X  0.01
2011 Cho YJ, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG, Lau CC, Olson JM, Gilbertson RJ, Gajjar A, Delattre O, et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1424-30. PMID 21098324 DOI: 10.1200/Jco.2010.28.5148  1
2011 Lee BS, Frankfort BJ, Eberhart CG, Weinberg RS. Diagnosis of intravascular lymphoma by a novel biopsy site. Ophthalmology. 118: 586-90. PMID 21035865 DOI: 10.1016/J.Ophtha.2010.08.001  0.01
2011 Shahi MH, Afzal M, Sinha S, Eberhart CG, Rey JA, Fan X, Castresana JS. Human hedgehog interacting protein expression and promoter methylation in medulloblastoma cell lines and primary tumor samples. Journal of Neuro-Oncology. 103: 287-96. PMID 20853133 DOI: 10.1007/S11060-010-0401-8  1
2011 Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, Rutka JT, Pfister S, Taylor MD. Medulloblastoma comprises four distinct molecular variants. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1408-14. PMID 20823417 DOI: 10.1200/Jco.2009.27.4324  1
2011 Sell S. Cancer Stem Cells: What are they? Where do they come from? What can we do about them Journal of Cell Science & Therapy. 1. DOI: 10.4172/2157-7013.S1.02  0.01
2011 Lim KS, Bar EE, Raabe EH, Jain D, Eberhart CG. Abstract 3459: Expression of oncogene-induced senescence markers in pilocytic astrocytomaIs associated with younger age and longer survival Cancer Research. 71: 3459-3459. DOI: 10.1158/1538-7445.Am2011-3459  1
2011 Mao X, Raabe EH, Maciaczyk J, Kahlert U, Nikkhah G, Eberhart CG. Abstract 3454: LIN28 is expressed in glioblastomas and promotes KRAS-mediated transformation of human neural stem cells Cancer Research. 71: 3454-3454. DOI: 10.1158/1538-7445.Am2011-3454  1
2011 Raabe EH, Lim KS, Mao X, Bar E, Meeker A, Kahlert U, Maciaczyk J, Nikkhah G, Eberhart CG. Abstract 3303: BRAF activation induces cellular transformation and senescence and down-regulates SOX2 in human neural stem cells: a model of pilocytic astrocytoma Cancer Research. 71: 3303-3303. DOI: 10.1158/1538-7445.Am2011-3303  1
2011 Ying M, Sang Y, Li Y, Guerrero-Cazares H, Quinones-Hinojosa A, Vescovi AL, Eberhart CG, Xia S, Laterra J. Abstract 3296: KLF9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells Cancer Research. 71: 3296-3296. DOI: 10.1158/1538-7445.Am2011-3296  1
2011 Kahlert U, Maciaczyk D, Nikkhah G, Simons B, Orr B, Eberhart C, Maciaczyk J. Abstract 2903: The role of canonical WNT/β-catenin signaling in glial tumors Cancer Research. 71: 2903-2903. DOI: 10.1158/1538-7445.Am2011-2903  1
2011 Asnaghi L, Coonfield ML, Schreck KC, Bar EE, Handa J, Merbs S, Ebrahimi KB, Harbour JW, Eberhart CG. Abstract 1415: The Notch ligand Jag 2 promotes growth and invasion in uveal melanoma cells Cancer Research. 71: 1415-1415. DOI: 10.1158/1538-7445.Am2011-1415  1
2011 Moriera F, So K, Gould P, Kamnasaran D, Jensen RL, Hussain I, Gutmann DH, Gorovets D, Kastenhuber ER, Pentsova E, Nayak L, Huse JT, van den Bent MJ, Gravendeel LA, Gorlia T, et al. -OMICS AND PROGNOSTIC MARKERS Neuro-Oncology. 13: iii76-iii84. DOI: 10.1093/Neuonc/Nor167  0.01
2010 Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, Gaiano N, Eberhart CG. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 6060-70. PMID 21169257 DOI: 10.1158/1078-0432.Ccr-10-1624  1
2010 Johnson MW, Eberhart CG, Perry A, Tihan T, Cohen KJ, Rosenblum MK, Rais-Bahrami S, Goldthwaite P, Burger PC. Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors. The American Journal of Surgical Pathology. 34: 1783-91. PMID 21107083 DOI: 10.1097/Pas.0B013E3181Fd66C3  1
2010 Shahi MH, Afzal M, Sinha S, Eberhart CG, Rey JA, Fan X, Castresana JS. Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma. Bmc Cancer. 10: 614. PMID 21059263 DOI: 10.1186/1471-2407-10-614  1
2010 Pfister SM, Korshunov A, Kool M, Hasselblatt M, Eberhart C, Taylor MD. Molecular diagnostics of CNS embryonal tumors. Acta Neuropathologica. 120: 553-66. PMID 20882288 DOI: 10.1007/S00401-010-0751-5  0.01
2010 Singh K, Rajan KD, Eberhart C. Orbital necrobiotic xanthogranuloma associated with systemic IgG4 disease. Ocular Immunology and Inflammation. 18: 373-8. PMID 20716008 DOI: 10.3109/09273948.2010.490629  1
2010 Jain D, Singh K, Chirumamilla S, Bibat GM, Blue ME, Naidu SR, Eberhart CG. Ocular MECP2 protein expression in patients with and without Rett syndrome. Pediatric Neurology. 43: 35-40. PMID 20682201 DOI: 10.1016/J.Pediatrneurol.2010.02.018  1
2010 Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. The American Journal of Pathology. 177: 1491-502. PMID 20671264 DOI: 10.2353/Ajpath.2010.091021  1
2010 Siu IM, Tyler BM, Chen JX, Eberhart CG, Thomale UW, Olivi A, Jallo GI, Riggins GJ, Gallia GL. Establishment of a human glioblastoma stemlike brainstem rodent tumor model. Journal of Neurosurgery. Pediatrics. 6: 92-7. PMID 20593994 DOI: 10.3171/2010.3.Peds09366  1
2010 Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Goggins M, Eberhart CG, Clark DP, Bieberich CJ, Epstein JI, De Marzo AM. NKX3.1 as a marker of prostatic origin in metastatic tumors. The American Journal of Surgical Pathology. 34: 1097-105. PMID 20588175 DOI: 10.1097/Pas.0B013E3181E6Cbf3  1
2010 Jain D, Ebrahimi KB, Miller NR, Eberhart CG. Intraorbital meningiomas: a pathologic review using current World Health Organization criteria. Archives of Pathology & Laboratory Medicine. 134: 766-70. PMID 20441509 DOI: 10.1043/1543-2165-134.5.766  1
2010 Yustein JT, Liu YC, Gao P, Jie C, Le A, Vuica-Ross M, Chng WJ, Eberhart CG, Bergsagel PL, Dang CV. Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model. Proceedings of the National Academy of Sciences of the United States of America. 107: 3534-9. PMID 20133585 DOI: 10.1073/Pnas.0901230107  1
2010 Engler C, Kelliher C, Spitze AR, Speck CL, Eberhart CG, Jun AS. Unfolded protein response in fuchs endothelial corneal dystrophy: a unifying pathogenic pathway? American Journal of Ophthalmology. 149: 194-202.e2. PMID 20103053 DOI: 10.1016/J.Ajo.2009.09.009  1
2010 Nakahara Y, Northcott PA, Li M, Kongkham PN, Smith C, Yan H, Croul S, Ra YS, Eberhart C, Huang A, Bigner D, Grajkowska W, Van Meter T, Rutka JT, Taylor MD. Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma. Neoplasia (New York, N.Y.). 12: 20-7. PMID 20072650 DOI: 10.1593/Neo.91122  1
2010 Raabe EH, Eberhart CG. High-risk medulloblastoma: does c-myc amplification overrule histopathology? Pediatric Blood & Cancer. 54: 344-5. PMID 20063409 DOI: 10.1002/Pbc.22398  1
2010 Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells (Dayton, Ohio). 28: 5-16. PMID 19904829 DOI: 10.1002/Stem.254  1
2010 Shahi MH, Fan X, Sinha S, Afzal M, Eberhart C, Castresana JS. Abstract 5150: Differential epigenetic regulation of sonic hedgehog GLI1 on downstream target genes in medulloblastoma and astrocytomas Cancer Research. 70: 5150-5150. DOI: 10.1158/1538-7445.Am10-5150  1
2010 Lim KJ, Maitra A, Bisht S, Eberhart C, Bar E. Abstract 4440: Using nanocurcumin to treat medulloblastoma and glioblastoma Cancer Research. 70: 4440-4440. DOI: 10.1158/1538-7445.Am10-4440  1
2010 Raabe EH, Maciaczyk J, Kahlert U, Nikkhah G, Eberhart C. Abstract 4352: Using human neural stem cells to model pediatric high grade gliomas: The role of p53, c-myc, and EGFRvIII in neoplastic transformation Cancer Research. 70: 4352-4352. DOI: 10.1158/1538-7445.Am10-4352  1
2010 Wu X, Collier L, Northcott P, Dubuc A, Eberhart C, Meter TV, Zagzag D, Croul S, Dupuy A, Scheetz TE, Scherer S, Bouffet E, Weiss WA, Largaespada DAD, Taylor MD. Abstract 4350: Clonal selection and parallel evolution during leptomeningeal dissemination of human and mouse medulloblastoma result in bicompartmental disease Cancer Research. 70: 4350-4350. DOI: 10.1158/1538-7445.Am10-4350  1
2010 Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart C, Mack S, Bouffet E, Clifford SC, Hawkins C, French P, Rutka JT, Pfister S, Taylor MD. Abstract 4347: Medulloblastoma comprises four distinct diseases Cancer Research. 70: 4347-4347. DOI: 10.1158/1538-7445.Am10-4347  1
2010 Li Y, Lal B, Cázares HG, Quinones-Hinjosa A, Eberhart C, Laterra J. Abstract 4285: C-Met signaling supports a stem-like transcriptional program and phenotype in glioblastoma Cancer Research. 70: 4285-4285. DOI: 10.1158/1538-7445.Am10-4285  1
2010 Asnaghi L, Coonfield ML, Schreck KC, Bar EE, Handa J, Merbs S, Ebrahimi K, Harbour JW, Eberhart CG. Abstract 4141: Notch signaling: A new potential target in the treatment of uveal melanoma Cancer Research. 70: 4141-4141. DOI: 10.1158/1538-7445.Am10-4141  1
2010 Schreck KC, Taylor P, Bar EE, Gopalakrishnan V, Gaiano N, Eberhart CG. Abstract 14: Targeting Notch in malignant brain tumors: Crosstalk with Hedgehog as a potential mechanism of treatment resistance Cancer Research. 70: 14-14. DOI: 10.1158/1538-7445.Am10-14  1
2010 Eberhart CG. Nervous System (Cambridge Illustrated Surgical Pathology) Journal of Neuropathology and Experimental Neurology. 69: 109-109. DOI: 10.1097/Nen.0B013E3181C948C2  0.01
2010 Wilkins S, Briggs K, McCaw A, Eberhart C, Watkins D_. Transcriptional targets of the tumour suppressor HIC1 in glioblastoma multiforme Neuroscience Research. 68. DOI: 10.1016/J.Neures.2010.07.1903  0.01
2010 Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C, Peter Collins V, Van Meter T, Picard D, Zhou L, Boutros P, Modena P, Liang ML, Scherer SW, Bouffet E, et al. Frequent Amplification of a chr19q13.41 MicroRNA Polycistron in Aggressive Primitive Neuroectodermal Brain Tumors (DOI:10.1016/j.ccr.2009.10.025) Cancer Cell. 17: 413. DOI: 10.1016/J.Ccr.2010.03.016  1
2009 Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C, Collins VP, Van Meter T, Picard D, Zhou L, Boutros PC, Modena P, Liang ML, Scherer SW, Bouffet E, et al. Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell. 16: 533-46. PMID 19962671 DOI: 10.1016/J.Ccr.2009.10.025  1
2009 Sabet-Peyman EJ, Eberhart CG, Janjua K, Shah SM, Do DV, Nguyen QD. Persistent intermediate uveitis associated with latent manifestation of facial large B-cell non-Hodgkin lymphoma. Ocular Immunology and Inflammation. 17: 322-4. PMID 19831563 DOI: 10.3109/09273940903043048  1
2009 Ayres B, Miller NR, Eberhart CG, Dibernardo CW. Ultrasound features of orbital granular cell tumor. Ophthalmic Plastic and Reconstructive Surgery. 25: 320-2. PMID 19617798 DOI: 10.1097/Iop.0B013E3181Aad8E0  1
2009 Nasonkin I, Mahairaki V, Xu L, Hatfield G, Cummings BJ, Eberhart C, Ryugo DK, Maric D, Bar E, Koliatsos VE. Long-term, stable differentiation of human embryonic stem cell-derived neural precursors grafted into the adult mammalian neostriatum. Stem Cells (Dayton, Ohio). 27: 2414-26. PMID 19609935 DOI: 10.1002/Stem.177  1
2009 Roda RH, Gallia GL, Eberhart CG, Weingart JD, Laterra J. Epilepsy and temporal lobe injury after skull base proton beam therapy. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 16: 1220-1. PMID 19576784 DOI: 10.1016/J.Jocn.2009.04.003  1
2009 Sun P, Xia S, Lal B, Eberhart CG, Quinones-Hinojosa A, Maciaczyk J, Matsui W, Dimeco F, Piccirillo SM, Vescovi AL, Laterra J. DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells (Dayton, Ohio). 27: 1473-86. PMID 19544453 DOI: 10.1002/Stem.89  1
2009 Quigley HA, Silver DM, Friedman DS, He M, Plyler RJ, Eberhart CG, Jampel HD, Ramulu P. Iris cross-sectional area decreases with pupil dilation and its dynamic behavior is a risk factor in angle closure. Journal of Glaucoma. 18: 173-9. PMID 19295366 DOI: 10.1097/Ijg.0B013E31818624Ce  0.01
2009 Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, Croul S, Mack S, Kongkham PN, Peacock J, Dubuc A, Ra YS, Zilberberg K, McLeod J, Scherer SW, Sunil Rao J, ... Eberhart CG, et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nature Genetics. 41: 465-72. PMID 19270706 DOI: 10.1038/Ng.336  1
2009 Mullendore ME, Koorstra JB, Li YM, Offerhaus GJ, Fan X, Henderson CM, Matsui W, Eberhart CG, Maitra A, Feldmann G. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2291-301. PMID 19258443 DOI: 10.1158/1078-0432.Ccr-08-2004  1
2009 von Bueren AO, Shalaby T, Oehler-Jänne C, Arnold L, Stearns D, Eberhart CG, Arcaro A, Pruschy M, Grotzer MA. RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. Bmc Cancer. 9: 10. PMID 19134217 DOI: 10.1186/1471-2407-9-10  1
2009 Barnes M, Eberhart CG, Collins R, Tihan T. Expression of p75NTR in fetal brain and medulloblastomas: evidence of a precursor cell marker and its persistence in neoplasia. Journal of Neuro-Oncology. 92: 193-201. PMID 19066726 DOI: 10.1007/S11060-008-9755-6  1
2009 Gessi M, Giangaspero F, Lauriola L, Gardiman M, Scheithauer BW, Halliday W, Hawkins C, Rosenblum MK, Burger PC, Eberhart CG. Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor. The American Journal of Surgical Pathology. 33: 211-7. PMID 18987548 DOI: 10.1097/Pas.0B013E318186235B  1
2009 Oster SF, Ebrahimi KB, Eberhart CG, Schein OD, Stark WJ, Jun AS. A clinicopathologic series of primary graft failure after Descemet's stripping and automated endothelial keratoplasty. Ophthalmology. 116: 609-14. PMID 18962919 DOI: 10.1016/J.Ophtha.2008.08.036  1
2009 Macgregor AM, Eberhart CG, Fraig M, Lu J, Halushka MK. Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney, and eye increase with age. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 57: 207-13. PMID 18955737 DOI: 10.1369/Jhc.2008.952531  1
2008 Pierfelice TJ, Schreck KC, Eberhart CG, Gaiano N. Notch, neural stem cells, and brain tumors. Cold Spring Harbor Symposia On Quantitative Biology. 73: 367-75. PMID 19022772 DOI: 10.1101/Sqb.2008.73.013  1
2008 Rodriguez FJ, Giannini C, Asmann YW, Sharma MK, Perry A, Tibbetts KM, Jenkins RB, Scheithauer BW, Anant S, Jenkins S, Eberhart CG, Sarkaria JN, Gutmann DH. Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes. Journal of Neuropathology and Experimental Neurology. 67: 1194-204. PMID 19018242 DOI: 10.1097/Nen.0B013E31818Fbe1E  1
2008 Briggs KJ, Eberhart CG, Watkins DN. Just say no to ATOH: how HIC1 methylation might predispose medulloblastoma to lineage addiction. Cancer Research. 68: 8654-6. PMID 18974104 DOI: 10.1158/0008-5472.Can-08-1904  1
2008 Yi JM, Tsai HC, Glöckner SC, Lin S, Ohm JE, Easwaran H, James CD, Costello JF, Riggins G, Eberhart CG, Laterra J, Vescovi AL, Ahuja N, Herman JG, Schuebel KE, et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Research. 68: 8094-103. PMID 18829568 DOI: 10.1158/0008-5472.Can-07-6208  1
2008 Binning MJ, Niazi T, Pedone CA, Lal B, Eberhart CG, Kim KJ, Laterra J, Fults DW. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth. Cancer Research. 68: 7838-45. PMID 18829539 DOI: 10.1158/0008-5472.Can-08-1899  1
2008 Bar EE, Lin A, Tihan T, Burger PC, Eberhart CG. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. Journal of Neuropathology and Experimental Neurology. 67: 878-87. PMID 18716556 DOI: 10.1097/Nen.0B013E3181845622  1
2008 Siu IM, Bai R, Gallia GL, Edwards JB, Tyler BM, Eberhart CG, Riggins GJ. Coexpression of neuronatin splice forms promotes medulloblastoma growth. Neuro-Oncology. 10: 716-24. PMID 18701710 DOI: 10.1215/15228517-2008-038  1
2008 Eberhart CG. Even cancers want commitment: lineage identity and medulloblastoma formation. Cancer Cell. 14: 105-7. PMID 18691544 DOI: 10.1016/J.Ccr.2008.07.011  0.01
2008 Fan X, Eberhart CG. Medulloblastoma stem cells. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2821-7. PMID 18539960 DOI: 10.1200/Jco.2007.15.2264  1
2008 Chen CS, Miller NR, Lane A, Eberhart C. Third cranial nerve palsy caused by intracranial extension of a sino-orbital natural killer T-cell lymphoma Journal of Neuro-Ophthalmology. 28: 31-35. PMID 18347456 DOI: 10.1097/Wno.0B013E3181674228  1
2008 Briggs KJ, Corcoran-Schwartz IM, Zhang W, Harcke T, Devereux WL, Baylin SB, Eberhart CG, Watkins DN. Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma. Genes & Development. 22: 770-85. PMID 18347096 DOI: 10.1101/Gad.1640908  1
2008 Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, Hansen S, Knoblaugh SE, Lee D, Eberhart CG, Hallahan AR, Olson JM. The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread. Cancer Research. 68: 1768-76. PMID 18339857 DOI: 10.1158/0008-5472.Can-07-5092  1
2008 Walker BM, Hindman HB, Ebrahimi KB, Green WR, Eberhart CG, Garcia I, Jun AS. Epithelial downgrowth following Descemet's-stripping automated endothelial keratoplasty. Archives of Ophthalmology (Chicago, Ill. : 1960). 126: 278-80. PMID 18268229 DOI: 10.1001/Archophthalmol.2007.58  1
2008 Li Y, Guessous F, Johnson EB, Eberhart CG, Li XN, Shu Q, Fan S, Lal B, Laterra J, Schiff D, Abounader R. Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 98-111. PMID 18059365 DOI: 10.1038/Labinvest.3700702  1
2007 Lo KC, Ma C, Bundy BN, Pomeroy SL, Eberhart CG, Cowell JK. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7022-8. PMID 18056178 DOI: 10.1158/1078-0432.Ccr-07-1420  1
2007 Pardo CA, Eberhart CG. The neurobiology of autism. Brain Pathology (Zurich, Switzerland). 17: 434-47. PMID 17919129 DOI: 10.1111/J.1750-3639.2007.00102.X  1
2007 Li T, Wen H, Brayton C, Laird FM, Ma G, Peng S, Placanica L, Wu TC, Crain BJ, Price DL, Eberhart CG, Wong PC. Moderate reduction of gamma-secretase attenuates amyloid burden and limits mechanism-based liabilities. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 10849-59. PMID 17913918 DOI: 10.1523/Jneurosci.2152-07.2007  1
2007 Li T, Wen H, Brayton C, Das P, Smithson LA, Fauq A, Fan X, Crain BJ, Price DL, Golde TE, Eberhart CG, Wong PC. Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretase. The Journal of Biological Chemistry. 282: 32264-73. PMID 17827153 DOI: 10.1074/Jbc.M703649200  1
2007 Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W, Piccirillo S, Vescovi AL, DiMeco F, Olivi A, Eberhart CG. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells (Dayton, Ohio). 25: 2524-33. PMID 17628016 DOI: 10.1634/Stemcells.2007-0166  1
2007 Rodriguez FJ, Eberhart C, O'Neill BP, Slezak J, Burger PC, Goldthwaite P, Wu W, Giannini C. Histopathologic grading of adult medulloblastomas. Cancer. 109: 2557-65. PMID 17487854 DOI: 10.1002/Cncr.22717  1
2007 Lo KC, Rossi MR, Eberhart CG, Cowell JK. Genome wide copy number abnormalities in pediatric medulloblastomas as assessed by array comparative genome hybridization. Brain Pathology (Zurich, Switzerland). 17: 282-96. PMID 17465989 DOI: 10.1111/J.1750-3639.2007.00072.X  1
2007 von Bueren AO, Shalaby T, Rajtarova J, Stearns D, Eberhart CG, Helson L, Arcaro A, Grotzer MA. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells. Bmc Cancer. 7: 19. PMID 17254356 DOI: 10.1186/1471-2407-7-19  1
2007 Eberhart CG. In search of the medulloblast: neural stem cells and embryonal brain tumors. Neurosurgery Clinics of North America. 18: 59-69, viii-ix. PMID 17244554 DOI: 10.1016/J.Nec.2006.10.005  0.01
2007 Bar EE, Chaudhry A, Farah MH, Eberhart CG. Hedgehog signaling promotes medulloblastoma survival via Bc/II. The American Journal of Pathology. 170: 347-55. PMID 17200206 DOI: 10.2353/Ajpath.2007.060066  1
2007 Cheslack-Postava K, Fallin MD, Avramopoulos D, Connors SL, Zimmerman AW, Eberhart CG, Newschaffer CJ. beta2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort. Molecular Psychiatry. 12: 283-91. PMID 17199132 DOI: 10.1038/Sj.Mp.4001940  1
2006 Gallia GL, Rand V, Siu IM, Eberhart CG, James CD, Marie SK, Oba-Shinjo SM, Carlotti CG, Caballero OL, Simpson AJ, Brock MV, Massion PP, Carson BS, Riggins GJ. PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. Molecular Cancer Research : McR. 4: 709-14. PMID 17050665 DOI: 10.1158/1541-7786.Mcr-06-0172  1
2006 Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, Eberhart CG. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Research. 66: 7445-52. PMID 16885340 DOI: 10.1158/0008-5472.Can-06-0858  1
2006 Chu LC, Eberhart CG, Grossman SA, Herman JG. Epigenetic silencing of multiple genes in primary CNS lymphoma. International Journal of Cancer. Journal International Du Cancer. 119: 2487-91. PMID 16858686 DOI: 10.1002/Ijc.22124  1
2006 Eberhart CG, Copeland J, Abel TW. Brief report: S6 ribosomal protein phosphorylation in autistic frontal cortex and cerebellum: a tissue array analysis. Journal of Autism and Developmental Disorders. 36: 1131-5. PMID 16845579 DOI: 10.1007/S10803-006-0135-9  1
2006 Park JT, Li M, Nakayama K, Mao TL, Davidson B, Zhang Z, Kurman RJ, Eberhart CG, Shih IeM, Wang TL. Notch3 gene amplification in ovarian cancer. Cancer Research. 66: 6312-8. PMID 16778208 DOI: 10.1158/0008-5472.Can-05-3610  0.01
2006 Dixit VD, Weeraratna AT, Yang H, Bertak D, Cooper-Jenkins A, Riggins GJ, Eberhart CG, Taub DD. Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility. The Journal of Biological Chemistry. 281: 16681-90. PMID 16527811 DOI: 10.1074/Jbc.M600223200  1
2006 Su X, Gopalakrishnan V, Stearns D, Aldape K, Lang FF, Fuller G, Snyder E, Eberhart CG, Majumder S. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation. Molecular and Cellular Biology. 26: 1666-78. PMID 16478988 DOI: 10.1128/Mcb.26.5.1666-1678.2006  1
2006 Stearns D, Chaudhry A, Abel TW, Burger PC, Dang CV, Eberhart CG. c-myc overexpression causes anaplasia in medulloblastoma. Cancer Research. 66: 673-81. PMID 16423996 DOI: 10.1158/0008-5472.Can-05-1580  1
2006 Dang L, Fan X, Chaudhry A, Wang M, Gaiano N, Eberhart CG. Notch3 signaling initiates choroid plexus tumor formation. Oncogene. 25: 487-91. PMID 16186803 DOI: 10.1038/Sj.Onc.1209074  1
2005 Connors SL, Crowell DE, Eberhart CG, Copeland J, Newschaffer CJ, Spence SJ, Zimmerman AW. beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins. Journal of Child Neurology. 20: 876-84. PMID 16417856 DOI: 10.1177/08830738050200110401  1
2005 Inda MM, Perot C, Guillaud-Bataille M, Danglot G, Rey JA, Bello MJ, Fan X, Eberhart C, Zazpe I, Portillo E, Tuñón T, Martínez-Peñuela JM, Bernheim A, Castresana JS. Genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumours of the central nervous system Histopathology. 47: 631-637. PMID 16324202 DOI: 10.1111/J.1365-2559.2005.02304.X  1
2005 Uziel T, Zindy F, Xie S, Lee Y, Forget A, Magdaleno S, Rehg JE, Calabrese C, Solecki D, Eberhart CG, Sherr SE, Plimmer S, Clifford SC, Hatten ME, McKinnon PJ, et al. The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes & Development. 19: 2656-67. PMID 16260494 DOI: 10.1101/Gad.1368605  1
2005 Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Cancer Research. 65: 9355-62. PMID 16230398 DOI: 10.1158/0008-5472.Can-05-1946  1
2005 Raza SM, Anderson WS, Eberhart CG, Wolinsky JP, Gokaslan ZL. The application of surgical cordectomy in the management of an intramedullary-extramedullary atypical meningioma: case report and literature review. Journal of Spinal Disorders & Techniques. 18: 449-54. PMID 16189459 DOI: 10.1097/01.Bsd.0000155032.69394.23  0.01
2005 Rand V, Huang J, Stockwell T, Ferriera S, Buzko O, Levy S, Busam D, Li K, Edwards JB, Eberhart C, Murphy KM, Tsiamouri A, Beeson K, Simpson AJ, Venter JC, et al. Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. Proceedings of the National Academy of Sciences of the United States of America. 102: 14344-9. PMID 16186508 DOI: 10.1073/Pnas.0507200102  1
2005 Pan E, Pellarin M, Holmes E, Smirnov I, Misra A, Eberhart CG, Burger PC, Biegel JA, Feuerstein BG. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4733-40. PMID 16000568 DOI: 10.1158/1078-0432.Ccr-04-0465  1
2005 Abel TW, Baker SJ, Fraser MM, Tihan T, Nelson JS, Yachnis AT, Bouffard JP, Mena H, Burger PC, Eberhart CG. Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. Journal of Neuropathology and Experimental Neurology. 64: 341-9. PMID 15835270 DOI: 10.1093/Jnen/64.4.341  1
2005 Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, Maric D, Eberhart CG, Fine HA. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Research. 65: 2353-63. PMID 15781650 DOI: 10.1158/0008-5472.Can-04-1890  1
2005 Eberhart CG, Chaudhry A, Daniel RW, Khaki L, Shah KV, Gravitt PE. Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus. Bmc Cancer. 5: 19. PMID 15717928 DOI: 10.1186/1471-2407-5-19  1
2005 Boon K, Eberhart CG, Riggins GJ. Genomic amplification of orthodenticle homologue 2 in medulloblastomas. Cancer Research. 65: 703-7. PMID 15705863  1
2004 Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, Ball D, Brat DJ, Perry A, Eberhart CG. Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Research. 64: 7787-93. PMID 15520184 DOI: 10.1158/0008-5472.Can-04-1446  1
2004 Boon K, Edwards JB, Eberhart CG, Riggins GJ. Identification of astrocytoma associated genes including cell surface markers. Bmc Cancer. 4: 39. PMID 15265232 DOI: 10.1186/1471-2407-4-39  1
2004 Eberhart CG, Kratz J, Wang Y, Summers K, Stearns D, Cohen K, Dang CV, Burger PC. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. Journal of Neuropathology and Experimental Neurology. 63: 441-9. PMID 15198123 DOI: 10.1093/Jnen/63.5.441  1
2004 Samdani AF, Garonzik IM, Jallo G, Eberhart CG, Zahos P. Spinal angiolipoma: case report and review of the literature. Acta Neurochirurgica. 146: 299-302; discussion . PMID 15015054 DOI: 10.1007/S00701-003-0196-X  1
2004 Fisher PG, Burger PC, Eberhart CG. Biologic risk stratification of medulloblastoma: the real time is now. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 971-4. PMID 14970187 DOI: 10.1200/Jco.2004.12.939  1
Show low-probability matches.